Attachment A.xlsx
XLSX spreadsheet 60 KB Posted
- Solicitation number
- 36C26226Q0329
About this file
This is a pricing attachment (Attachment A.xlsx) for a federal contract opportunity related to laboratory testing services. The document contains a detailed line-item pricing schedule organized into a base period and four option periods, with identical service listings across all periods. The contract covers 157 line items for immunohistochemistry (IHC), in situ hybridization (ISH), fluorescence in situ hybridization (FISH), next-generation sequencing (NGS), and flow cytometry testing services, all to be provided by NeoGenomics as the specified manufacturer/service provider.
The pricing schedule includes specialized diagnostic tests covering tissue-based markers and panels, including oncology-related assays such as HER2 testing for breast and gastric cancers, PD-L1 testing with FDA-approved antibodies (22C3 for Keytruda, 28-8 for Opdivo, and SP142 for Tecentriq), mismatch repair panel testing, various immunophenotyping panels (breast panels with 2-4 stains, AML MRD flow panel, HPV RNA ISH panel), and molecular analyses (B-cell and T-cell gene rearrangement, mutation analysis). Quantities vary by line item, ranging from 2 to 66 units across the base and option periods. All unit prices and extended prices are listed as "$-0," indicating this is a template document with pricing to be populated during the solicitation response phase. The contract is for the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| RFI Doc.docx | DOCX document | |
| SOW.pdf | ||
| 36C26226Q0329.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
1. Base
| CLIN | Brand Name | Brand Name Nomenclature | Manufacturer Part Number | Salient Characteristics | Equivalent Brand | Equivalent Nomenclature | Equivalent Part Number | Equivalent Description Matching Salient Characteristics and/or location of information regarding equal capability | Quantity | Unit Price | Extended Price |
| 1 | (T) DDIT3 (CHOP)(12q13) | NEOGENOMICS | (T) DDIT3 (CHOP)(12q13) | See SOW | 2 | $ - 0 | |||||
| 2 | (T) H&E | NEOGENOMICS | (T) H&E | See SOW | 11 | $ - 0 | |||||
| 3 | (T) HER2 Breast | NEOGENOMICS | (T) HER2 Breast | See SOW | 3 | $ - 0 | |||||
| 4 | (T) HER2 Gastric/GEA | NEOGENOMICS | (T) HER2 Gastric/GEA | See SOW | 2 | $ - 0 | |||||
| 5 | (T) MDM2 | NEOGENOMICS | (T) MDM2 | See SOW | 8 | $ - 0 | |||||
| 6 | (P) AML MRD Flow Panel | NEOGENOMICS | (P) AML MRD Flow Panel | See SOW | 2 | $ - 0 | |||||
| 7 | (P) Amyloid A & P | NEOGENOMICS | (P) Amyloid A & P | See SOW | 3 | $ - 0 | |||||
| 8 | (P) Breast Panel (2 Stain) | NEOGENOMICS | (P) Breast Panel (2 Stain) | See SOW | 4 | $ - 0 | |||||
| 9 | (P) Breast Panel (3 Stain) | NEOGENOMICS | (P) Breast Panel (3 Stain) | See SOW | 4 | $ - 0 | |||||
| 10 | (P) Breast Panel (4 Stain) | NEOGENOMICS | (P) Breast Panel (4 Stain) | See SOW | 2 | $ - 0 | |||||
| 11 | (P) HPV RNA ISH Panel | NEOGENOMICS | (P) HPV RNA ISH Panel | See SOW | 8 | $ - 0 | |||||
| 12 | (P) Mismatch Repair (MMR) IHC Panel Qualitative | NEOGENOMICS | (P) Mismatch Repair (MMR) IHC Panel Qualitative | See SOW | 3 | $ - 0 | |||||
| 13 | (T) AFP | NEOGENOMICS | (T) AFP | See SOW | 4 | $ - 0 | |||||
| 14 | (T) Albumin RNA ISH | NEOGENOMICS | (T) Albumin RNA ISH | See SOW | 3 | $ - 0 | |||||
| 15 | (T) ALK (D5F3) | NEOGENOMICS | (T) ALK (D5F3) | See SOW | 4 | $ - 0 | |||||
| 16 | (T) ALK-1 (for Heme cases) | NEOGENOMICS | (T) ALK-1 (for Heme cases) | See SOW | 17 | $ - 0 | |||||
| 17 | (T) AR | NEOGENOMICS | (T) AR | See SOW | 2 | $ - 0 | |||||
| 18 | (T) AR Qualitative | NEOGENOMICS | (T) AR Qualitative | See SOW | 2 | $ - 0 | |||||
| 19 | (T) Arginase 1 | NEOGENOMICS | (T) Arginase 1 | See SOW | 12 | $ - 0 | |||||
| 20 | (T) BOB1 | NEOGENOMICS | (T) BOB1 | See SOW | 2 | $ - 0 | |||||
| 21 | (T) CA19.9 | NEOGENOMICS | (T) CA19.9 | See SOW | 2 | $ - 0 | |||||
| 22 | (T) Calcitonin | NEOGENOMICS | (T) Calcitonin | See SOW | 2 | $ - 0 | |||||
| 23 | (T) Calponin | NEOGENOMICS | (T) Calponin | See SOW | 2 | $ - 0 | |||||
| 24 | (T) Calretinin | NEOGENOMICS | (T) Calretinin | See SOW | 2 | $ - 0 | |||||
| 25 | (T) CD1a | NEOGENOMICS | (T) CD1a | See SOW | 3 | $ - 0 | |||||
| 26 | (T) CD2 | NEOGENOMICS | (T) CD2 | See SOW | 2 | $ - 0 | |||||
| 27 | (T) CD14 | NEOGENOMICS | (T) CD14 | See SOW | 2 | $ - 0 | |||||
| 28 | (T) CD15 | NEOGENOMICS | (T) CD15 | See SOW | 2 | $ - 0 | |||||
| 29 | (T) CD23 | NEOGENOMICS | (T) CD23 | See SOW | 4 | $ - 0 | |||||
| 30 | (T) CD25 | NEOGENOMICS | (T) CD25 | See SOW | 4 | $ - 0 | |||||
| 31 | (T) CD33 | NEOGENOMICS | (T) CD33 | See SOW | 2 | $ - 0 | |||||
| 32 | (T) CD42b | NEOGENOMICS | (T) CD42b | See SOW | 4 | $ - 0 | |||||
| 33 | (T) CD44 | NEOGENOMICS | (T) CD44 | See SOW | 5 | $ - 0 | |||||
| 34 | (T) CD61 | NEOGENOMICS | (T) CD61 | See SOW | 9 | $ - 0 | |||||
| 35 | (T) CD71 | NEOGENOMICS | (T) CD71 | See SOW | 4 | $ - 0 | |||||
| 36 | (T) CD79a | NEOGENOMICS | (T) CD79a | See SOW | 7 | $ - 0 | |||||
| 37 | (T) CD117 cKIT | NEOGENOMICS | (T) CD117 cKIT | See SOW | 3 | $ - 0 | |||||
| 38 | (T) CD123 | NEOGENOMICS | (T) CD123 | See SOW | 8 | $ - 0 | |||||
| 39 | (T) CD163 | NEOGENOMICS | (T) CD163 | See SOW | 3 | $ - 0 | |||||
| 40 | (T) CEA (Poly) | NEOGENOMICS | (T) CEA (Poly) | See SOW | 3 | $ - 0 | |||||
| 41 | (T) CK 7 | NEOGENOMICS | (T) CK 7 | See SOW | 7 | $ - 0 | |||||
| 42 | (T) CK 19 | NEOGENOMICS | (T) CK 19 | See SOW | 9 | $ - 0 | |||||
| 43 | (T) CK OSCAR | NEOGENOMICS | (T) CK OSCAR | See SOW | 7 | $ - 0 | |||||
| 44 | (T) Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma | NEOGENOMICS | (T) Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma | See SOW | 3 | $ - 0 | |||||
| 45 | (T) CMV by IHC | NEOGENOMICS | (T) CMV by IHC | See SOW | 28 | $ - 0 | |||||
| 46 | (T) cMyc | NEOGENOMICS | (T) cMyc | See SOW | 5 | $ - 0 | |||||
| 47 | (T) Congo Red | NEOGENOMICS | (T) Congo Red | See SOW | 3 | $ - 0 | |||||
| 48 | (T) CXCL13 | NEOGENOMICS | (T) CXCL13 | See SOW | 4 | $ - 0 | |||||
| 49 | (T) Desmin | NEOGENOMICS | (T) Desmin | See SOW | 2 | $ - 0 | |||||
| 50 | (T) DOG1 | NEOGENOMICS | (T) DOG1 | See SOW | 3 | $ - 0 | |||||
| 51 | (T) E-Cadherin | NEOGENOMICS | (T) E-Cadherin | See SOW | 6 | $ - 0 | |||||
| 52 | (T) EBER ISH | NEOGENOMICS | (T) EBER ISH | See SOW | 26 | $ - 0 | |||||
| 53 | (T) EBV (LMP1) | NEOGENOMICS | (T) EBV (LMP1) | See SOW | 2 | $ - 0 | |||||
| 54 | (T) Elastic Stain | NEOGENOMICS | (T) Elastic Stain | See SOW | 3 | $ - 0 | |||||
| 55 | (T) ER | NEOGENOMICS | (T) ER | See SOW | 3 | $ - 0 | |||||
| 56 | (T) ER Qualitative | NEOGENOMICS | (T) ER Qualitative | See SOW | 8 | $ - 0 | |||||
| 57 | (T) ERG | NEOGENOMICS | (T) ERG | See SOW | 7 | $ - 0 | |||||
| 58 | (T) Factor XIIIa | NEOGENOMICS | (T) Factor XIIIa | See SOW | 2 | $ - 0 | |||||
| 59 | (T) Fli-1 | NEOGENOMICS | (T) Fli-1 | See SOW | 2 | $ - 0 | |||||
| 60 | (T) Gastrin | NEOGENOMICS | (T) Gastrin | See SOW | 5 | $ - 0 | |||||
| 61 | (T) GCDFP15 | NEOGENOMICS | (T) GCDFP15 | See SOW | 2 | $ - 0 | |||||
| 62 | (T) Glypican-3 | NEOGENOMICS | (T) Glypican-3 | See SOW | 12 | $ - 0 | |||||
| 63 | (T) GMS | NEOGENOMICS | (T) GMS | See SOW | 12 | $ - 0 | |||||
| 64 | (T) Gram Stain | NEOGENOMICS | (T) Gram Stain | See SOW | 8 | $ - 0 | |||||
| 65 | (T) Granzyme B | NEOGENOMICS | (T) Granzyme B | See SOW | 4 | $ - 0 | |||||
| 66 | (T) H3K27me3 | NEOGENOMICS | (T) H3K27me3 | See SOW | 2 | $ - 0 | |||||
| 67 | (T) H. Pylori | NEOGENOMICS | (T) H. Pylori | See SOW | 7 | $ - 0 | |||||
| 68 | (T) HCG Beta | NEOGENOMICS | (T) HCG Beta | See SOW | 2 | $ - 0 | |||||
| 69 | (T) HER2 (Other) – with Breast Scoring | NEOGENOMICS | (T) HER2 (Other) – with Breast Scoring | See SOW | 7 | $ - 0 | |||||
| 70 | (T) HER2 (Other) – with Gastric Scoring | NEOGENOMICS | (T) HER2 (Other) – with Gastric Scoring | See SOW | 2 | $ - 0 | |||||
| 71 | (T) HER2 Breast | NEOGENOMICS | (T) HER2 Breast | See SOW | 5 | $ - 0 | |||||
| 72 | (T) HER2 Gastric/GEA | NEOGENOMICS | (T) HER2 Gastric/GEA | See SOW | 10 | $ - 0 | |||||
| 73 | (T) HHV8 | NEOGENOMICS | (T) HHV8 | See SOW | 11 | $ - 0 | |||||
| 74 | (T) Histology Other | NEOGENOMICS | (T) Histology Other | See SOW | 5 | $ - 0 | |||||
| 75 | (T) HMB45 | NEOGENOMICS | (T) HMB45 | See SOW | 2 | $ - 0 | |||||
| 76 | (T) HPV RNA ISH High Risk Cocktail | NEOGENOMICS | (T) HPV RNA ISH High Risk Cocktail | See SOW | 9 | $ - 0 | |||||
| 77 | (T) HPV RNA ISH Low Risk Cocktail | NEOGENOMICS | (T) HPV RNA ISH Low Risk Cocktail | See SOW | 9 | $ - 0 | |||||
| 78 | (T) HSV1/2 | NEOGENOMICS | (T) HSV1/2 | See SOW | 11 | $ - 0 | |||||
| 79 | (T) ICOS | NEOGENOMICS | (T) ICOS | See SOW | 3 | $ - 0 | |||||
| 80 | (T) Ig G | NEOGENOMICS | (T) Ig G | See SOW | 11 | $ - 0 | |||||
| 81 | (T) IgG4 | NEOGENOMICS | (T) IgG4 | See SOW | 11 | $ - 0 | |||||
| 82 | (T) Inhibin | NEOGENOMICS | (T) Inhibin | See SOW | 2 | $ - 0 | |||||
| 83 | (T) INI1 | NEOGENOMICS | (T) INI1 | See SOW | 2 | $ - 0 | |||||
| 84 | (T) INSM1 | NEOGENOMICS | (T) INSM1 | See SOW | 4 | $ - 0 | |||||
| 85 | (T) Ki67 | NEOGENOMICS | (T) Ki67 | See SOW | 3 | $ - 0 | |||||
| 86 | (T) Langerin | NEOGENOMICS | (T) Langerin | See SOW | 2 | $ - 0 | |||||
| 87 | (T) LEF1 | NEOGENOMICS | (T) LEF1 | See SOW | 2 | $ - 0 | |||||
| 88 | (T) LMO2 | NEOGENOMICS | (T) LMO2 | See SOW | 2 | $ - 0 | |||||
| 89 | (T) Mammaglobin | NEOGENOMICS | (T) Mammaglobin | See SOW | 5 | $ - 0 | |||||
| 90 | (T) MPO | NEOGENOMICS | (T) MPO | See SOW | 4 | $ - 0 | |||||
| 91 | (T) MSH2 Qualitative | NEOGENOMICS | (T) MSH2 Qualitative | See SOW | 3 | $ - 0 | |||||
| 92 | (T) MUC1 | NEOGENOMICS | (T) MUC1 | See SOW | 2 | $ - 0 | |||||
| 93 | (T) MUC2 | NEOGENOMICS | (T) MUC2 | See SOW | 2 | $ - 0 | |||||
| 94 | (T) MUC5 | NEOGENOMICS | (T) MUC5 | See SOW | 2 | $ - 0 | |||||
| 95 | (T) MUC6 | NEOGENOMICS | (T) MUC6 | See SOW | 2 | $ - 0 | |||||
| 96 | (T) MUM1 | NEOGENOMICS | (T) MUM1 | See SOW | 19 | $ - 0 | |||||
| 97 | (T) NF (Neurofilament) | NEOGENOMICS | (T) NF (Neurofilament) | See SOW | 2 | $ - 0 | |||||
| 98 | (T) NKX2.2 | NEOGENOMICS | (T) NKX2.2 | See SOW | 2 | $ - 0 | |||||
| 99 | (T) NKX3.1 | NEOGENOMICS | (T) NKX3.1 | See SOW | 3 | $ - 0 | |||||
| 100 | (T) OCT2 | NEOGENOMICS | (T) OCT2 | See SOW | 3 | $ - 0 | |||||
| 101 | (T) OCT4 | NEOGENOMICS | (T) OCT4 | See SOW | 4 | $ - 0 | |||||
| 102 | (T) p40 | NEOGENOMICS | (T) p40 | See SOW | 2 | $ - 0 | |||||
| 103 | (T) P63 | NEOGENOMICS | (T) P63 | See SOW | 2 | $ - 0 | |||||
| 104 | (T) P504S | NEOGENOMICS | (T) P504S | See SOW | 2 | $ - 0 | |||||
| 105 | (T) Pan-Cytokeratin | NEOGENOMICS | (T) Pan-Cytokeratin | See SOW | 7 | $ - 0 | |||||
| 106 | (T) PAS | NEOGENOMICS | (T) PAS | See SOW | 2 | $ - 0 | |||||
| 107 | (T) PAX2 | NEOGENOMICS | (T) PAX2 | See SOW | 2 | $ - 0 | |||||
| 108 | (T) PAX5 | NEOGENOMICS | (T) PAX5 | See SOW | 5 | $ - 0 | |||||
| 109 | (T) PD1 | NEOGENOMICS | (T) PD1 | See SOW | 6 | $ - 0 | |||||
| 110 | (T) PD-L1 22C3 FDA (KEYTRUDA®) for Gastric/GEA | NEOGENOMICS | (T) PD-L1 22C3 FDA (KEYTRUDA®) for Gastric/GEA | See SOW | 2 | $ - 0 | |||||
| 111 | (T) PD-L1 22C3 FDA (KEYTRUDA®) for HNSCC (Head and Neck) | NEOGENOMICS | (T) PD-L1 22C3 FDA (KEYTRUDA®) for HNSCC (Head and Neck) | See SOW | 12 | $ - 0 | |||||
| 112 | (T) PD-L1 22C3 FDA for NSCLC | NEOGENOMICS | (T) PD-L1 22C3 FDA for NSCLC | See SOW | 66 | $ - 0 | |||||
| 113 | (T) PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/EAC | NEOGENOMICS | (T) PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/EAC | See SOW | 7 | $ - 0 | |||||
| 114 | (T) PD-L1 28-8 FDA for NSCLC | NEOGENOMICS | (T) PD-L1 28-8 FDA for NSCLC | See SOW | 3 | $ - 0 | |||||
| 115 | (T) PD-L1 SP142 FDA (TECENTRIQ®) for NSCLC | NEOGENOMICS | (T) PD-L1 SP142 FDA (TECENTRIQ®) for NSCLC | See SOW | 2 | $ - 0 | |||||
| 116 | (T) Periodic Acid Schiff with Digestion (PASD) | NEOGENOMICS | (T) Periodic Acid Schiff with Digestion (PASD) | See SOW | 5 | $ - 0 | |||||
| 117 | (T) PgR | NEOGENOMICS | (T) PgR | See SOW | 3 | $ - 0 | |||||
| 118 | (T) PLAP | NEOGENOMICS | (T) PLAP | See SOW | 2 | $ - 0 | |||||
| 119 | (T) PMS2 | NEOGENOMICS | (T) PMS2 | See SOW | 7 | $ - 0 | |||||
| 120 | (T) PMS2 Qualitative | NEOGENOMICS | (T) PMS2 Qualitative | See SOW | 26 | $ - 0 | |||||
| 121 | (T) PSA | NEOGENOMICS | (T) PSA | See SOW | 2 | $ - 0 | |||||
| 122 | (T) PTH | NEOGENOMICS | (T) PTH | See SOW | 2 | $ - 0 | |||||
| 123 | (T) Retinoblastoma Protein (RB) | NEOGENOMICS | (T) Retinoblastoma Protein (RB) | See SOW | 3 | $ - 0 | |||||
| 124 | (T) S100 | NEOGENOMICS | (T) S100 | See SOW | 6 | $ - 0 | |||||
| 125 | (T) SATB2 | NEOGENOMICS | (T) SATB2 | See SOW | 3 | $ - 0 | |||||
| 126 | (T) SMA | NEOGENOMICS | (T) SMA | See SOW | 2 | $ - 0 | |||||
| 127 | (T) SMMHC | NEOGENOMICS | (T) SMMHC | See SOW | 2 | $ - 0 | |||||
| 128 | (T) Somatostatin Receptor, Type 2 | NEOGENOMICS | (T) Somatostatin Receptor, Type 2 | See SOW | 3 | $ - 0 | |||||
| 129 | (T) SOX10 | NEOGENOMICS | (T) SOX10 | See SOW | 2 | $ - 0 | |||||
| 130 | (T) SOX11 | NEOGENOMICS | (T) SOX11 | See SOW | 3 | $ - 0 | |||||
| 131 | (T) Spirochete | NEOGENOMICS | (T) Spirochete | See SOW | 4 | $ - 0 | |||||
| 132 | (T) STAT6 | NEOGENOMICS | (T) STAT6 | See SOW | 5 | $ - 0 | |||||
| 133 | (T) Synaptophysin | NEOGENOMICS | (T) Synaptophysin | See SOW | 2 | $ - 0 | |||||
| 134 | (T) TCL1 | NEOGENOMICS | (T) TCL1 | See SOW | 4 | $ - 0 | |||||
| 135 | (T) TdT | NEOGENOMICS | (T) TdT | See SOW | 6 | $ - 0 | |||||
| 136 | (T) TIA1 | NEOGENOMICS | (T) TIA1 | See SOW | 3 | $ - 0 | |||||
| 137 | (T) TLE1 | NEOGENOMICS | (T) TLE1 | See SOW | 2 | $ - 0 | |||||
| 138 | (T) Toxoplasma | NEOGENOMICS | (T) Toxoplasma | See SOW | 2 | $ - 0 | |||||
| 139 | (T) Trichrome | NEOGENOMICS | (T) Trichrome | See SOW | 4 | $ - 0 | |||||
| 140 | (T) Tryptase | NEOGENOMICS | (T) Tryptase | See SOW | 4 | $ - 0 | |||||
| 141 | (T) TTF1 | NEOGENOMICS | (T) TTF1 | See SOW | 6 | $ - 0 | |||||
| 142 | (T) Uroplakin II | NEOGENOMICS | (T) Uroplakin II | See SOW | 2 | $ - 0 | |||||
| 143 | (T) Uroplakin III | NEOGENOMICS | (T) Uroplakin III | See SOW | 2 | $ - 0 | |||||
| 144 | (T) Villin | NEOGENOMICS | (T) Villin | See SOW | 2 | $ - 0 | |||||
| 145 | (T) WT1 | NEOGENOMICS | (T) WT1 | See SOW | 8 | $ - 0 | |||||
| 146 | (P) NeoTYPE® ALL Profile (Molecular Only) | NEOGENOMICS | (P) NeoTYPE® ALL Profile (Molecular Only) | See SOW | 2 | $ - 0 | |||||
| 147 | (P) Sarcoma Comprehensive NGS Fusion Panel | NEOGENOMICS | (P) Sarcoma Comprehensive NGS Fusion Panel | See SOW | 2 | $ - 0 | |||||
| 148 | (T) B-Cell Gene Rearrangement | NEOGENOMICS | (T) B-Cell Gene Rearrangement | See SOW | 3 | $ - 0 | |||||
| 149 | (T) CXCR4 Mutation Analysis | NEOGENOMICS | (T) CXCR4 Mutation Analysis | See SOW | 2 | $ - 0 | |||||
| 150 | (T) MLH1 Promoter Methylation Analysis | NEOGENOMICS | (T) MLH1 Promoter Methylation Analysis | See SOW | 2 | $ - 0 | |||||
| 151 | (T) MYD88 Mutation Analysis | NEOGENOMICS | (T) MYD88 Mutation Analysis | See SOW | 2 | $ - 0 | |||||
| 152 | (T) T-Cell Receptor Beta Gene Rearrangement | NEOGENOMICS | (T) T-Cell Receptor Beta Gene Rearrangement | See SOW | 6 | $ - 0 | |||||
| 153 | (T) T-Cell Receptor Gamma Gene Rearrangement | NEOGENOMICS | (T) T-Cell Receptor Gamma Gene Rearrangement | See SOW | 6 | $ - 0 | |||||
| 154 | Calcium stain | NEOGENOMICS | Calcium stain | See SOW | 11 | $ - 0 | |||||
| 155 | MLH1 Qualitative | NEOGENOMICS | MLH1 Qualitative | See SOW | 3 | $ - 0 | |||||
| 156 | MSH6 Qualitative | NEOGENOMICS | MSH6 Qualitative | See SOW | 3 | $ - 0 | |||||
| 157 | Periodic Acid Schiff for Fungus (PASF) | NEOGENOMICS | Periodic Acid Schiff for Fungus (PASF) | See SOW | 12 | $ - 0 | |||||
| $ - 0 | |||||||||||
| Total | $ - 0 |
2. Option 1
| CLIN | Brand Name | Brand Name Nomenclature | Manufacturer Part Number | Salient Characteristics | Equivalent Brand | Equivalent Nomenclature | Equivalent Part Number | Equivalent Description Matching Salient Characteristics and/or location of information regarding equal capability | Quantity | Unit Price | Extended Price |
| 1 | (T) DDIT3 (CHOP)(12q13) | NEOGENOMICS | (T) DDIT3 (CHOP)(12q13) | See SOW | 2 | $ - 0 | |||||
| 2 | (T) H&E | NEOGENOMICS | (T) H&E | See SOW | 11 | $ - 0 | |||||
| 3 | (T) HER2 Breast | NEOGENOMICS | (T) HER2 Breast | See SOW | 3 | $ - 0 | |||||
| 4 | (T) HER2 Gastric/GEA | NEOGENOMICS | (T) HER2 Gastric/GEA | See SOW | 2 | $ - 0 | |||||
| 5 | (T) MDM2 | NEOGENOMICS | (T) MDM2 | See SOW | 8 | $ - 0 | |||||
| 6 | (P) AML MRD Flow Panel | NEOGENOMICS | (P) AML MRD Flow Panel | See SOW | 2 | $ - 0 | |||||
| 7 | (P) Amyloid A & P | NEOGENOMICS | (P) Amyloid A & P | See SOW | 3 | $ - 0 | |||||
| 8 | (P) Breast Panel (2 Stain) | NEOGENOMICS | (P) Breast Panel (2 Stain) | See SOW | 4 | $ - 0 | |||||
| 9 | (P) Breast Panel (3 Stain) | NEOGENOMICS | (P) Breast Panel (3 Stain) | See SOW | 4 | $ - 0 | |||||
| 10 | (P) Breast Panel (4 Stain) | NEOGENOMICS | (P) Breast Panel (4 Stain) | See SOW | 2 | $ - 0 | |||||
| 11 | (P) HPV RNA ISH Panel | NEOGENOMICS | (P) HPV RNA ISH Panel | See SOW | 8 | $ - 0 | |||||
| 12 | (P) Mismatch Repair (MMR) IHC Panel Qualitative | NEOGENOMICS | (P) Mismatch Repair (MMR) IHC Panel Qualitative | See SOW | 3 | $ - 0 | |||||
| 13 | (T) AFP | NEOGENOMICS | (T) AFP | See SOW | 4 | $ - 0 | |||||
| 14 | (T) Albumin RNA ISH | NEOGENOMICS | (T) Albumin RNA ISH | See SOW | 3 | $ - 0 | |||||
| 15 | (T) ALK (D5F3) | NEOGENOMICS | (T) ALK (D5F3) | See SOW | 4 | $ - 0 | |||||
| 16 | (T) ALK-1 (for Heme cases) | NEOGENOMICS | (T) ALK-1 (for Heme cases) | See SOW | 17 | $ - 0 | |||||
| 17 | (T) AR | NEOGENOMICS | (T) AR | See SOW | 2 | $ - 0 | |||||
| 18 | (T) AR Qualitative | NEOGENOMICS | (T) AR Qualitative | See SOW | 2 | $ - 0 | |||||
| 19 | (T) Arginase 1 | NEOGENOMICS | (T) Arginase 1 | See SOW | 12 | $ - 0 | |||||
| 20 | (T) BOB1 | NEOGENOMICS | (T) BOB1 | See SOW | 2 | $ - 0 | |||||
| 21 | (T) CA19.9 | NEOGENOMICS | (T) CA19.9 | See SOW | 2 | $ - 0 | |||||
| 22 | (T) Calcitonin | NEOGENOMICS | (T) Calcitonin | See SOW | 2 | $ - 0 | |||||
| 23 | (T) Calponin | NEOGENOMICS | (T) Calponin | See SOW | 2 | $ - 0 | |||||
| 24 | (T) Calretinin | NEOGENOMICS | (T) Calretinin | See SOW | 2 | $ - 0 | |||||
| 25 | (T) CD1a | NEOGENOMICS | (T) CD1a | See SOW | 3 | $ - 0 | |||||
| 26 | (T) CD2 | NEOGENOMICS | (T) CD2 | See SOW | 2 | $ - 0 | |||||
| 27 | (T) CD14 | NEOGENOMICS | (T) CD14 | See SOW | 2 | $ - 0 | |||||
| 28 | (T) CD15 | NEOGENOMICS | (T) CD15 | See SOW | 2 | $ - 0 | |||||
| 29 | (T) CD23 | NEOGENOMICS | (T) CD23 | See SOW | 4 | $ - 0 | |||||
| 30 | (T) CD25 | NEOGENOMICS | (T) CD25 | See SOW | 4 | $ - 0 | |||||
| 31 | (T) CD33 | NEOGENOMICS | (T) CD33 | See SOW | 2 | $ - 0 | |||||
| 32 | (T) CD42b | NEOGENOMICS | (T) CD42b | See SOW | 4 | $ - 0 | |||||
| 33 | (T) CD44 | NEOGENOMICS | (T) CD44 | See SOW | 5 | $ - 0 | |||||
| 34 | (T) CD61 | NEOGENOMICS | (T) CD61 | See SOW | 9 | $ - 0 | |||||
| 35 | (T) CD71 | NEOGENOMICS | (T) CD71 | See SOW | 4 | $ - 0 | |||||
| 36 | (T) CD79a | NEOGENOMICS | (T) CD79a | See SOW | 7 | $ - 0 | |||||
| 37 | (T) CD117 cKIT | NEOGENOMICS | (T) CD117 cKIT | See SOW | 3 | $ - 0 | |||||
| 38 | (T) CD123 | NEOGENOMICS | (T) CD123 | See SOW | 8 | $ - 0 | |||||
| 39 | (T) CD163 | NEOGENOMICS | (T) CD163 | See SOW | 3 | $ - 0 | |||||
| 40 | (T) CEA (Poly) | NEOGENOMICS | (T) CEA (Poly) | See SOW | 3 | $ - 0 | |||||
| 41 | (T) CK 7 | NEOGENOMICS | (T) CK 7 | See SOW | 7 | $ - 0 | |||||
| 42 | (T) CK 19 | NEOGENOMICS | (T) CK 19 | See SOW | 9 | $ - 0 | |||||
| 43 | (T) CK OSCAR | NEOGENOMICS | (T) CK OSCAR | See SOW | 7 | $ - 0 | |||||
| 44 | (T) Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma | NEOGENOMICS | (T) Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma | See SOW | 3 | $ - 0 | |||||
| 45 | (T) CMV by IHC | NEOGENOMICS | (T) CMV by IHC | See SOW | 28 | $ - 0 | |||||
| 46 | (T) cMyc | NEOGENOMICS | (T) cMyc | See SOW | 5 | $ - 0 | |||||
| 47 | (T) Congo Red | NEOGENOMICS | (T) Congo Red | See SOW | 3 | $ - 0 | |||||
| 48 | (T) CXCL13 | NEOGENOMICS | (T) CXCL13 | See SOW | 4 | $ - 0 | |||||
| 49 | (T) Desmin | NEOGENOMICS | (T) Desmin | See SOW | 2 | $ - 0 | |||||
| 50 | (T) DOG1 | NEOGENOMICS | (T) DOG1 | See SOW | 3 | $ - 0 | |||||
| 51 | (T) E-Cadherin | NEOGENOMICS | (T) E-Cadherin | See SOW | 6 | $ - 0 | |||||
| 52 | (T) EBER ISH | NEOGENOMICS | (T) EBER ISH | See SOW | 26 | $ - 0 | |||||
| 53 | (T) EBV (LMP1) | NEOGENOMICS | (T) EBV (LMP1) | See SOW | 2 | $ - 0 | |||||
| 54 | (T) Elastic Stain | NEOGENOMICS | (T) Elastic Stain | See SOW | 3 | $ - 0 | |||||
| 55 | (T) ER | NEOGENOMICS | (T) ER | See SOW | 3 | $ - 0 | |||||
| 56 | (T) ER Qualitative | NEOGENOMICS | (T) ER Qualitative | See SOW | 8 | $ - 0 | |||||
| 57 | (T) ERG | NEOGENOMICS | (T) ERG | See SOW | 7 | $ - 0 | |||||
| 58 | (T) Factor XIIIa | NEOGENOMICS | (T) Factor XIIIa | See SOW | 2 | $ - 0 | |||||
| 59 | (T) Fli-1 | NEOGENOMICS | (T) Fli-1 | See SOW | 2 | $ - 0 | |||||
| 60 | (T) Gastrin | NEOGENOMICS | (T) Gastrin | See SOW | 5 | $ - 0 | |||||
| 61 | (T) GCDFP15 | NEOGENOMICS | (T) GCDFP15 | See SOW | 2 | $ - 0 | |||||
| 62 | (T) Glypican-3 | NEOGENOMICS | (T) Glypican-3 | See SOW | 12 | $ - 0 | |||||
| 63 | (T) GMS | NEOGENOMICS | (T) GMS | See SOW | 12 | $ - 0 | |||||
| 64 | (T) Gram Stain | NEOGENOMICS | (T) Gram Stain | See SOW | 8 | $ - 0 | |||||
| 65 | (T) Granzyme B | NEOGENOMICS | (T) Granzyme B | See SOW | 4 | $ - 0 | |||||
| 66 | (T) H3K27me3 | NEOGENOMICS | (T) H3K27me3 | See SOW | 2 | $ - 0 | |||||
| 67 | (T) H. Pylori | NEOGENOMICS | (T) H. Pylori | See SOW | 7 | $ - 0 | |||||
| 68 | (T) HCG Beta | NEOGENOMICS | (T) HCG Beta | See SOW | 2 | $ - 0 | |||||
| 69 | (T) HER2 (Other) – with Breast Scoring | NEOGENOMICS | (T) HER2 (Other) – with Breast Scoring | See SOW | 7 | $ - 0 | |||||
| 70 | (T) HER2 (Other) – with Gastric Scoring | NEOGENOMICS | (T) HER2 (Other) – with Gastric Scoring | See SOW | 2 | $ - 0 | |||||
| 71 | (T) HER2 Breast | NEOGENOMICS | (T) HER2 Breast | See SOW | 5 | $ - 0 | |||||
| 72 | (T) HER2 Gastric/GEA | NEOGENOMICS | (T) HER2 Gastric/GEA | See SOW | 10 | $ - 0 | |||||
| 73 | (T) HHV8 | NEOGENOMICS | (T) HHV8 | See SOW | 11 | $ - 0 | |||||
| 74 | (T) Histology Other | NEOGENOMICS | (T) Histology Other | See SOW | 5 | $ - 0 | |||||
| 75 | (T) HMB45 | NEOGENOMICS | (T) HMB45 | See SOW | 2 | $ - 0 | |||||
| 76 | (T) HPV RNA ISH High Risk Cocktail | NEOGENOMICS | (T) HPV RNA ISH High Risk Cocktail | See SOW | 9 | $ - 0 | |||||
| 77 | (T) HPV RNA ISH Low Risk Cocktail | NEOGENOMICS | (T) HPV RNA ISH Low Risk Cocktail | See SOW | 9 | $ - 0 | |||||
| 78 | (T) HSV1/2 | NEOGENOMICS | (T) HSV1/2 | See SOW | 11 | $ - 0 | |||||
| 79 | (T) ICOS | NEOGENOMICS | (T) ICOS | See SOW | 3 | $ - 0 | |||||
| 80 | (T) Ig G | NEOGENOMICS | (T) Ig G | See SOW | 11 | $ - 0 | |||||
| 81 | (T) IgG4 | NEOGENOMICS | (T) IgG4 | See SOW | 11 | $ - 0 | |||||
| 82 | (T) Inhibin | NEOGENOMICS | (T) Inhibin | See SOW | 2 | $ - 0 | |||||
| 83 | (T) INI1 | NEOGENOMICS | (T) INI1 | See SOW | 2 | $ - 0 | |||||
| 84 | (T) INSM1 | NEOGENOMICS | (T) INSM1 | See SOW | 4 | $ - 0 | |||||
| 85 | (T) Ki67 | NEOGENOMICS | (T) Ki67 | See SOW | 3 | $ - 0 | |||||
| 86 | (T) Langerin | NEOGENOMICS | (T) Langerin | See SOW | 2 | $ - 0 | |||||
| 87 | (T) LEF1 | NEOGENOMICS | (T) LEF1 | See SOW | 2 | $ - 0 | |||||
| 88 | (T) LMO2 | NEOGENOMICS | (T) LMO2 | See SOW | 2 | $ - 0 | |||||
| 89 | (T) Mammaglobin | NEOGENOMICS | (T) Mammaglobin | See SOW | 5 | $ - 0 | |||||
| 90 | (T) MPO | NEOGENOMICS | (T) MPO | See SOW | 4 | $ - 0 | |||||
| 91 | (T) MSH2 Qualitative | NEOGENOMICS | (T) MSH2 Qualitative | See SOW | 3 | $ - 0 | |||||
| 92 | (T) MUC1 | NEOGENOMICS | (T) MUC1 | See SOW | 2 | $ - 0 | |||||
| 93 | (T) MUC2 | NEOGENOMICS | (T) MUC2 | See SOW | 2 | $ - 0 | |||||
| 94 | (T) MUC5 | NEOGENOMICS | (T) MUC5 | See SOW | 2 | $ - 0 | |||||
| 95 | (T) MUC6 | NEOGENOMICS | (T) MUC6 | See SOW | 2 | $ - 0 | |||||
| 96 | (T) MUM1 | NEOGENOMICS | (T) MUM1 | See SOW | 19 | $ - 0 | |||||
| 97 | (T) NF (Neurofilament) | NEOGENOMICS | (T) NF (Neurofilament) | See SOW | 2 | $ - 0 | |||||
| 98 | (T) NKX2.2 | NEOGENOMICS | (T) NKX2.2 | See SOW | 2 | $ - 0 | |||||
| 99 | (T) NKX3.1 | NEOGENOMICS | (T) NKX3.1 | See SOW | 3 | $ - 0 | |||||
| 100 | (T) OCT2 | NEOGENOMICS | (T) OCT2 | See SOW | 3 | $ - 0 | |||||
| 101 | (T) OCT4 | NEOGENOMICS | (T) OCT4 | See SOW | 4 | $ - 0 | |||||
| 102 | (T) p40 | NEOGENOMICS | (T) p40 | See SOW | 2 | $ - 0 | |||||
| 103 | (T) P63 | NEOGENOMICS | (T) P63 | See SOW | 2 | $ - 0 | |||||
| 104 | (T) P504S | NEOGENOMICS | (T) P504S | See SOW | 2 | $ - 0 | |||||
| 105 | (T) Pan-Cytokeratin | NEOGENOMICS | (T) Pan-Cytokeratin | See SOW | 7 | $ - 0 | |||||
| 106 | (T) PAS | NEOGENOMICS | (T) PAS | See SOW | 2 | $ - 0 | |||||
| 107 | (T) PAX2 | NEOGENOMICS | (T) PAX2 | See SOW | 2 | $ - 0 | |||||
| 108 | (T) PAX5 | NEOGENOMICS | (T) PAX5 | See SOW | 5 | $ - 0 | |||||
| 109 | (T) PD1 | NEOGENOMICS | (T) PD1 | See SOW | 6 | $ - 0 | |||||
| 110 | (T) PD-L1 22C3 FDA (KEYTRUDA®) for Gastric/GEA | NEOGENOMICS | (T) PD-L1 22C3 FDA (KEYTRUDA®) for Gastric/GEA | See SOW | 2 | $ - 0 | |||||
| 111 | (T) PD-L1 22C3 FDA (KEYTRUDA®) for HNSCC (Head and Neck) | NEOGENOMICS | (T) PD-L1 22C3 FDA (KEYTRUDA®) for HNSCC (Head and Neck) | See SOW | 12 | $ - 0 | |||||
| 112 | (T) PD-L1 22C3 FDA for NSCLC | NEOGENOMICS | (T) PD-L1 22C3 FDA for NSCLC | See SOW | 66 | $ - 0 | |||||
| 113 | (T) PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/EAC | NEOGENOMICS | (T) PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/EAC | See SOW | 7 | $ - 0 | |||||
| 114 | (T) PD-L1 28-8 FDA for NSCLC | NEOGENOMICS | (T) PD-L1 28-8 FDA for NSCLC | See SOW | 3 | $ - 0 | |||||
| 115 | (T) PD-L1 SP142 FDA (TECENTRIQ®) for NSCLC | NEOGENOMICS | (T) PD-L1 SP142 FDA (TECENTRIQ®) for NSCLC | See SOW | 2 | $ - 0 | |||||
| 116 | (T) Periodic Acid Schiff with Digestion (PASD) | NEOGENOMICS | (T) Periodic Acid Schiff with Digestion (PASD) | See SOW | 5 | $ - 0 | |||||
| 117 | (T) PgR | NEOGENOMICS | (T) PgR | See SOW | 3 | $ - 0 | |||||
| 118 | (T) PLAP | NEOGENOMICS | (T) PLAP | See SOW | 2 | $ - 0 | |||||
| 119 | (T) PMS2 | NEOGENOMICS | (T) PMS2 | See SOW | 7 | $ - 0 | |||||
| 120 | (T) PMS2 Qualitative | NEOGENOMICS | (T) PMS2 Qualitative | See SOW | 26 | $ - 0 | |||||
| 121 | (T) PSA | NEOGENOMICS | (T) PSA | See SOW | 2 | $ - 0 | |||||
| 122 | (T) PTH | NEOGENOMICS | (T) PTH | See SOW | 2 | $ - 0 | |||||
| 123 | (T) Retinoblastoma Protein (RB) | NEOGENOMICS | (T) Retinoblastoma Protein (RB) | See SOW | 3 | $ - 0 | |||||
| 124 | (T) S100 | NEOGENOMICS | (T) S100 | See SOW | 6 | $ - 0 | |||||
| 125 | (T) SATB2 | NEOGENOMICS | (T) SATB2 | See SOW | 3 | $ - 0 | |||||
| 126 | (T) SMA | NEOGENOMICS | (T) SMA | See SOW | 2 | $ - 0 | |||||
| 127 | (T) SMMHC | NEOGENOMICS | (T) SMMHC | See SOW | 2 | $ - 0 | |||||
| 128 | (T) Somatostatin Receptor, Type 2 | NEOGENOMICS | (T) Somatostatin Receptor, Type 2 | See SOW | 3 | $ - 0 | |||||
| 129 | (T) SOX10 | NEOGENOMICS | (T) SOX10 | See SOW | 2 | $ - 0 | |||||
| 130 | (T) SOX11 | NEOGENOMICS | (T) SOX11 | See SOW | 3 | $ - 0 | |||||
| 131 | (T) Spirochete | NEOGENOMICS | (T) Spirochete | See SOW | 4 | $ - 0 | |||||
| 132 | (T) STAT6 | NEOGENOMICS | (T) STAT6 | See SOW | 5 | $ - 0 | |||||
| 133 | (T) Synaptophysin | NEOGENOMICS | (T) Synaptophysin | See SOW | 2 | $ - 0 | |||||
| 134 | (T) TCL1 | NEOGENOMICS | (T) TCL1 | See SOW | 4 | $ - 0 | |||||
| 135 | (T) TdT | NEOGENOMICS | (T) TdT | See SOW | 6 | $ - 0 | |||||
| 136 | (T) TIA1 | NEOGENOMICS | (T) TIA1 | See SOW | 3 | $ - 0 | |||||
| 137 | (T) TLE1 | NEOGENOMICS | (T) TLE1 | See SOW | 2 | $ - 0 | |||||
| 138 | (T) Toxoplasma | NEOGENOMICS | (T) Toxoplasma | See SOW | 2 | $ - 0 | |||||
| 139 | (T) Trichrome | NEOGENOMICS | (T) Trichrome | See SOW | 4 | $ - 0 | |||||
| 140 | (T) Tryptase | NEOGENOMICS | (T) Tryptase | See SOW | 4 | $ - 0 | |||||
| 141 | (T) TTF1 | NEOGENOMICS | (T) TTF1 | See SOW | 6 | $ - 0 | |||||
| 142 | (T) Uroplakin II | NEOGENOMICS | (T) Uroplakin II | See SOW | 2 | $ - 0 | |||||
| 143 | (T) Uroplakin III | NEOGENOMICS | (T) Uroplakin III | See SOW | 2 | $ - 0 | |||||
| 144 | (T) Villin | NEOGENOMICS | (T) Villin | See SOW | 2 | $ - 0 | |||||
| 145 | (T) WT1 | NEOGENOMICS | (T) WT1 | See SOW | 8 | $ - 0 | |||||
| 146 | (P) NeoTYPE® ALL Profile (Molecular Only) | NEOGENOMICS | (P) NeoTYPE® ALL Profile (Molecular Only) | See SOW | 2 | $ - 0 | |||||
| 147 | (P) Sarcoma Comprehensive NGS Fusion Panel | NEOGENOMICS | (P) Sarcoma Comprehensive NGS Fusion Panel | See SOW | 2 | $ - 0 | |||||
| 148 | (T) B-Cell Gene Rearrangement | NEOGENOMICS | (T) B-Cell Gene Rearrangement | See SOW | 3 | $ - 0 | |||||
| 149 | (T) CXCR4 Mutation Analysis | NEOGENOMICS | (T) CXCR4 Mutation Analysis | See SOW | 2 | $ - 0 | |||||
| 150 | (T) MLH1 Promoter Methylation Analysis | NEOGENOMICS | (T) MLH1 Promoter Methylation Analysis | See SOW | 2 | $ - 0 | |||||
| 151 | (T) MYD88 Mutation Analysis | NEOGENOMICS | (T) MYD88 Mutation Analysis | See SOW | 2 | $ - 0 | |||||
| 152 | (T) T-Cell Receptor Beta Gene Rearrangement | NEOGENOMICS | (T) T-Cell Receptor Beta Gene Rearrangement | See SOW | 6 | $ - 0 | |||||
| 153 | (T) T-Cell Receptor Gamma Gene Rearrangement | NEOGENOMICS | (T) T-Cell Receptor Gamma Gene Rearrangement | See SOW | 6 | $ - 0 | |||||
| 154 | Calcium stain | NEOGENOMICS | Calcium stain | See SOW | 11 | $ - 0 | |||||
| 155 | MLH1 Qualitative | NEOGENOMICS | MLH1 Qualitative | See SOW | 3 | $ - 0 | |||||
| 156 | MSH6 Qualitative | NEOGENOMICS | MSH6 Qualitative | See SOW | 3 | $ - 0 | |||||
| 157 | Periodic Acid Schiff for Fungus (PASF) | NEOGENOMICS | Periodic Acid Schiff for Fungus (PASF) | See SOW | 12 | $ - 0 | |||||
| $ - 0 | |||||||||||
| Total | $ - 0 |
3. Option 2
| CLIN | Brand Name | Brand Name Nomenclature | Manufacturer Part Number | Salient Characteristics | Equivalent Brand | Equivalent Nomenclature | Equivalent Part Number | Equivalent Description Matching Salient Characteristics and/or location of information regarding equal capability | Quantity | Unit Price | Extended Price |
| 1 | (T) DDIT3 (CHOP)(12q13) | NEOGENOMICS | (T) DDIT3 (CHOP)(12q13) | See SOW | 2 | $ - 0 | |||||
| 2 | (T) H&E | NEOGENOMICS | (T) H&E | See SOW | 11 | $ - 0 | |||||
| 3 | (T) HER2 Breast | NEOGENOMICS | (T) HER2 Breast | See SOW | 3 | $ - 0 | |||||
| 4 | (T) HER2 Gastric/GEA | NEOGENOMICS | (T) HER2 Gastric/GEA | See SOW | 2 | $ - 0 | |||||
| 5 | (T) MDM2 | NEOGENOMICS | (T) MDM2 | See SOW | 8 | $ - 0 | |||||
| 6 | (P) AML MRD Flow Panel | NEOGENOMICS | (P) AML MRD Flow Panel | See SOW | 2 | $ - 0 | |||||
| 7 | (P) Amyloid A & P | NEOGENOMICS | (P) Amyloid A & P | See SOW | 3 | $ - 0 | |||||
| 8 | (P) Breast Panel (2 Stain) | NEOGENOMICS | (P) Breast Panel (2 Stain) | See SOW | 4 | $ - 0 | |||||
| 9 | (P) Breast Panel (3 Stain) | NEOGENOMICS | (P) Breast Panel (3 Stain) | See SOW | 4 | $ - 0 | |||||
| 10 | (P) Breast Panel (4 Stain) | NEOGENOMICS | (P) Breast Panel (4 Stain) | See SOW | 2 | $ - 0 | |||||
| 11 | (P) HPV RNA ISH Panel | NEOGENOMICS | (P) HPV RNA ISH Panel | See SOW | 8 | $ - 0 | |||||
| 12 | (P) Mismatch Repair (MMR) IHC Panel Qualitative | NEOGENOMICS | (P) Mismatch Repair (MMR) IHC Panel Qualitative | See SOW | 3 | $ - 0 | |||||
| 13 | (T) AFP | NEOGENOMICS | (T) AFP | See SOW | 4 | $ - 0 | |||||
| 14 | (T) Albumin RNA ISH | NEOGENOMICS | (T) Albumin RNA ISH | See SOW | 3 | $ - 0 | |||||
| 15 | (T) ALK (D5F3) | NEOGENOMICS | (T) ALK (D5F3) | See SOW | 4 | $ - 0 | |||||
| 16 | (T) ALK-1 (for Heme cases) | NEOGENOMICS | (T) ALK-1 (for Heme cases) | See SOW | 17 | $ - 0 | |||||
| 17 | (T) AR | NEOGENOMICS | (T) AR | See SOW | 2 | $ - 0 | |||||
| 18 | (T) AR Qualitative | NEOGENOMICS | (T) AR Qualitative | See SOW | 2 | $ - 0 | |||||
| 19 | (T) Arginase 1 | NEOGENOMICS | (T) Arginase 1 | See SOW | 12 | $ - 0 | |||||
| 20 | (T) BOB1 | NEOGENOMICS | (T) BOB1 | See SOW | 2 | $ - 0 | |||||
| 21 | (T) CA19.9 | NEOGENOMICS | (T) CA19.9 | See SOW | 2 | $ - 0 | |||||
| 22 | (T) Calcitonin | NEOGENOMICS | (T) Calcitonin | See SOW | 2 | $ - 0 | |||||
| 23 | (T) Calponin | NEOGENOMICS | (T) Calponin | See SOW | 2 | $ - 0 | |||||
| 24 | (T) Calretinin | NEOGENOMICS | (T) Calretinin | See SOW | 2 | $ - 0 | |||||
| 25 | (T) CD1a | NEOGENOMICS | (T) CD1a | See SOW | 3 | $ - 0 | |||||
| 26 | (T) CD2 | NEOGENOMICS | (T) CD2 | See SOW | 2 | $ - 0 | |||||
| 27 | (T) CD14 | NEOGENOMICS | (T) CD14 | See SOW | 2 | $ - 0 | |||||
| 28 | (T) CD15 | NEOGENOMICS | (T) CD15 | See SOW | 2 | $ - 0 | |||||
| 29 | (T) CD23 | NEOGENOMICS | (T) CD23 | See SOW | 4 | $ - 0 | |||||
| 30 | (T) CD25 | NEOGENOMICS | (T) CD25 | See SOW | 4 | $ - 0 | |||||
| 31 | (T) CD33 | NEOGENOMICS | (T) CD33 | See SOW | 2 | $ - 0 | |||||
| 32 | (T) CD42b | NEOGENOMICS | (T) CD42b | See SOW | 4 | $ - 0 | |||||
| 33 | (T) CD44 | NEOGENOMICS | (T) CD44 | See SOW | 5 | $ - 0 | |||||
| 34 | (T) CD61 | NEOGENOMICS | (T) CD61 | See SOW | 9 | $ - 0 | |||||
| 35 | (T) CD71 | NEOGENOMICS | (T) CD71 | See SOW | 4 | $ - 0 | |||||
| 36 | (T) CD79a | NEOGENOMICS | (T) CD79a | See SOW | 7 | $ - 0 | |||||
| 37 | (T) CD117 cKIT | NEOGENOMICS | (T) CD117 cKIT | See SOW | 3 | $ - 0 | |||||
| 38 | (T) CD123 | NEOGENOMICS | (T) CD123 | See SOW | 8 | $ - 0 | |||||
| 39 | (T) CD163 | NEOGENOMICS | (T) CD163 | See SOW | 3 | $ - 0 | |||||
| 40 | (T) CEA (Poly) | NEOGENOMICS | (T) CEA (Poly) | See SOW | 3 | $ - 0 | |||||
| 41 | (T) CK 7 | NEOGENOMICS | (T) CK 7 | See SOW | 7 | $ - 0 | |||||
| 42 | (T) CK 19 | NEOGENOMICS | (T) CK 19 | See SOW | 9 | $ - 0 | |||||
| 43 | (T) CK OSCAR | NEOGENOMICS | (T) CK OSCAR | See SOW | 7 | $ - 0 | |||||
| 44 | (T) Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma | NEOGENOMICS | (T) Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma | See SOW | 3 | $ - 0 | |||||
| 45 | (T) CMV by IHC | NEOGENOMICS | (T) CMV by IHC | See SOW | 28 | $ - 0 | |||||
| 46 | (T) cMyc | NEOGENOMICS | (T) cMyc | See SOW | 5 | $ - 0 | |||||
| 47 | (T) Congo Red | NEOGENOMICS | (T) Congo Red | See SOW | 3 | $ - 0 | |||||
| 48 | (T) CXCL13 | NEOGENOMICS | (T) CXCL13 | See SOW | 4 | $ - 0 | |||||
| 49 | (T) Desmin | NEOGENOMICS | (T) Desmin | See SOW | 2 | $ - 0 | |||||
| 50 | (T) DOG1 | NEOGENOMICS | (T) DOG1 | See SOW | 3 | $ - 0 | |||||
| 51 | (T) E-Cadherin | NEOGENOMICS | (T) E-Cadherin | See SOW | 6 | $ - 0 | |||||
| 52 | (T) EBER ISH | NEOGENOMICS | (T) EBER ISH | See SOW | 26 | $ - 0 | |||||
| 53 | (T) EBV (LMP1) | NEOGENOMICS | (T) EBV (LMP1) | See SOW | 2 | $ - 0 | |||||
| 54 | (T) Elastic Stain | NEOGENOMICS | (T) Elastic Stain | See SOW | 3 | $ - 0 | |||||
| 55 | (T) ER | NEOGENOMICS | (T) ER | See SOW | 3 | $ - 0 | |||||
| 56 | (T) ER Qualitative | NEOGENOMICS | (T) ER Qualitative | See SOW | 8 | $ - 0 | |||||
| 57 | (T) ERG | NEOGENOMICS | (T) ERG | See SOW | 7 | $ - 0 | |||||
| 58 | (T) Factor XIIIa | NEOGENOMICS | (T) Factor XIIIa | See SOW | 2 | $ - 0 | |||||
| 59 | (T) Fli-1 | NEOGENOMICS | (T) Fli-1 | See SOW | 2 | $ - 0 | |||||
| 60 | (T) Gastrin | NEOGENOMICS | (T) Gastrin | See SOW | 5 | $ - 0 | |||||
| 61 | (T) GCDFP15 | NEOGENOMICS | (T) GCDFP15 | See SOW | 2 | $ - 0 | |||||
| 62 | (T) Glypican-3 | NEOGENOMICS | (T) Glypican-3 | See SOW | 12 | $ - 0 | |||||
| 63 | (T) GMS | NEOGENOMICS | (T) GMS | See SOW | 12 | $ - 0 | |||||
| 64 | (T) Gram Stain | NEOGENOMICS | (T) Gram Stain | See SOW | 8 | $ - 0 | |||||
| 65 | (T) Granzyme B | NEOGENOMICS | (T) Granzyme B | See SOW | 4 | $ - 0 | |||||
| 66 | (T) H3K27me3 | NEOGENOMICS | (T) H3K27me3 | See SOW | 2 | $ - 0 | |||||
| 67 | (T) H. Pylori | NEOGENOMICS | (T) H. Pylori | See SOW | 7 | $ - 0 | |||||
| 68 | (T) HCG Beta | NEOGENOMICS | (T) HCG Beta | See SOW | 2 | $ - 0 | |||||
| 69 | (T) HER2 (Other) – with Breast Scoring | NEOGENOMICS | (T) HER2 (Other) – with Breast Scoring | See SOW | 7 | $ - 0 | |||||
| 70 | (T) HER2 (Other) – with Gastric Scoring | NEOGENOMICS | (T) HER2 (Other) – with Gastric Scoring | See SOW | 2 | $ - 0 | |||||
| 71 | (T) HER2 Breast | NEOGENOMICS | (T) HER2 Breast | See SOW | 5 | $ - 0 | |||||
| 72 | (T) HER2 Gastric/GEA | NEOGENOMICS | (T) HER2 Gastric/GEA | See SOW | 10 | $ - 0 | |||||
| 73 | (T) HHV8 | NEOGENOMICS | (T) HHV8 | See SOW | 11 | $ - 0 | |||||
| 74 | (T) Histology Other | NEOGENOMICS | (T) Histology Other | See SOW | 5 | $ - 0 | |||||
| 75 | (T) HMB45 | NEOGENOMICS | (T) HMB45 | See SOW | 2 | $ - 0 | |||||
| 76 | (T) HPV RNA ISH High Risk Cocktail | NEOGENOMICS | (T) HPV RNA ISH High Risk Cocktail | See SOW | 9 | $ - 0 | |||||
| 77 | (T) HPV RNA ISH Low Risk Cocktail | NEOGENOMICS | (T) HPV RNA ISH Low Risk Cocktail | See SOW | 9 | $ - 0 | |||||
| 78 | (T) HSV1/2 | NEOGENOMICS | (T) HSV1/2 | See SOW | 11 | $ - 0 | |||||
| 79 | (T) ICOS | NEOGENOMICS | (T) ICOS | See SOW | 3 | $ - 0 | |||||
| 80 | (T) Ig G | NEOGENOMICS | (T) Ig G | See SOW | 11 | $ - 0 | |||||
| 81 | (T) IgG4 | NEOGENOMICS | (T) IgG4 | See SOW | 11 | $ - 0 | |||||
| 82 | (T) Inhibin | NEOGENOMICS | (T) Inhibin | See SOW | 2 | $ - 0 | |||||
| 83 | (T) INI1 | NEOGENOMICS | (T) INI1 | See SOW | 2 | $ - 0 | |||||
| 84 | (T) INSM1 | NEOGENOMICS | (T) INSM1 | See SOW | 4 | $ - 0 | |||||
| 85 | (T) Ki67 | NEOGENOMICS | (T) Ki67 | See SOW | 3 | $ - 0 | |||||
| 86 | (T) Langerin | NEOGENOMICS | (T) Langerin | See SOW | 2 | $ - 0 | |||||
| 87 | (T) LEF1 | NEOGENOMICS | (T) LEF1 | See SOW | 2 | $ - 0 | |||||
| 88 | (T) LMO2 | NEOGENOMICS | (T) LMO2 | See SOW | 2 | $ - 0 | |||||
| 89 | (T) Mammaglobin | NEOGENOMICS | (T) Mammaglobin | See SOW | 5 | $ - 0 | |||||
| 90 | (T) MPO | NEOGENOMICS | (T) MPO | See SOW | 4 | $ - 0 | |||||
| 91 | (T) MSH2 Qualitative | NEOGENOMICS | (T) MSH2 Qualitative | See SOW | 3 | $ - 0 | |||||
| 92 | (T) MUC1 | NEOGENOMICS | (T) MUC1 | See SOW | 2 | $ - 0 | |||||
| 93 | (T) MUC2 | NEOGENOMICS | (T) MUC2 | See SOW | 2 | $ - 0 | |||||
| 94 | (T) MUC5 | NEOGENOMICS | (T) MUC5 | See SOW | 2 | $ - 0 | |||||
| 95 | (T) MUC6 | NEOGENOMICS | (T) MUC6 | See SOW | 2 | $ - 0 | |||||
| 96 | (T) MUM1 | NEOGENOMICS | (T) MUM1 | See SOW | 19 | $ - 0 | |||||
| 97 | (T) NF (Neurofilament) | NEOGENOMICS | (T) NF (Neurofilament) | See SOW | 2 | $ - 0 | |||||
| 98 | (T) NKX2.2 | NEOGENOMICS | (T) NKX2.2 | See SOW | 2 | $ - 0 | |||||
| 99 | (T) NKX3.1 | NEOGENOMICS | (T) NKX3.1 | See SOW | 3 | $ - 0 | |||||
| 100 | (T) OCT2 | NEOGENOMICS | (T) OCT2 | See SOW | 3 | $ - 0 | |||||
| 101 | (T) OCT4 | NEOGENOMICS | (T) OCT4 | See SOW | 4 | $ - 0 | |||||
| 102 | (T) p40 | NEOGENOMICS | (T) p40 | See SOW | 2 | $ - 0 | |||||
| 103 | (T) P63 | NEOGENOMICS | (T) P63 | See SOW | 2 | $ - 0 | |||||
| 104 | (T) P504S | NEOGENOMICS | (T) P504S | See SOW | 2 | $ - 0 | |||||
| 105 | (T) Pan-Cytokeratin | NEOGENOMICS | (T) Pan-Cytokeratin | See SOW | 7 | $ - 0 | |||||
| 106 | (T) PAS | NEOGENOMICS | (T) PAS | See SOW | 2 | $ - 0 | |||||
| 107 | (T) PAX2 | NEOGENOMICS | (T) PAX2 | See SOW | 2 | $ - 0 | |||||
| 108 | (T) PAX5 | NEOGENOMICS | (T) PAX5 | See SOW | 5 | $ - 0 | |||||
| 109 | (T) PD1 | NEOGENOMICS | (T) PD1 | See SOW | 6 | $ - 0 | |||||
| 110 | (T) PD-L1 22C3 FDA (KEYTRUDA®) for Gastric/GEA | NEOGENOMICS | (T) PD-L1 22C3 FDA (KEYTRUDA®) for Gastric/GEA | See SOW | 2 | $ - 0 | |||||
| 111 | (T) PD-L1 22C3 FDA (KEYTRUDA®) for HNSCC (Head and Neck) | NEOGENOMICS | (T) PD-L1 22C3 FDA (KEYTRUDA®) for HNSCC (Head and Neck) | See SOW | 12 | $ - 0 | |||||
| 112 | (T) PD-L1 22C3 FDA for NSCLC | NEOGENOMICS | (T) PD-L1 22C3 FDA for NSCLC | See SOW | 66 | $ - 0 | |||||
| 113 | (T) PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/EAC | NEOGENOMICS | (T) PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/EAC | See SOW | 7 | $ - 0 | |||||
| 114 | (T) PD-L1 28-8 FDA for NSCLC | NEOGENOMICS | (T) PD-L1 28-8 FDA for NSCLC | See SOW | 3 | $ - 0 | |||||
| 115 | (T) PD-L1 SP142 FDA (TECENTRIQ®) for NSCLC | NEOGENOMICS | (T) PD-L1 SP142 FDA (TECENTRIQ®) for NSCLC | See SOW | 2 | $ - 0 | |||||
| 116 | (T) Periodic Acid Schiff with Digestion (PASD) | NEOGENOMICS | (T) Periodic Acid Schiff with Digestion (PASD) | See SOW | 5 | $ - 0 | |||||
| 117 | (T) PgR | NEOGENOMICS | (T) PgR | See SOW | 3 | $ - 0 | |||||
| 118 | (T) PLAP | NEOGENOMICS | (T) PLAP | See SOW | 2 | $ - 0 | |||||
| 119 | (T) PMS2 | NEOGENOMICS | (T) PMS2 | See SOW | 7 | $ - 0 | |||||
| 120 | (T) PMS2 Qualitative | NEOGENOMICS | (T) PMS2 Qualitative | See SOW | 26 | $ - 0 | |||||
| 121 | (T) PSA | NEOGENOMICS | (T) PSA | See SOW | 2 | $ - 0 | |||||
| 122 | (T) PTH | NEOGENOMICS | (T) PTH | See SOW | 2 | $ - 0 | |||||
| 123 | (T) Retinoblastoma Protein (RB) | NEOGENOMICS | (T) Retinoblastoma Protein (RB) | See SOW | 3 | $ - 0 | |||||
| 124 | (T) S100 | NEOGENOMICS | (T) S100 | See SOW | 6 | $ - 0 | |||||
| 125 | (T) SATB2 | NEOGENOMICS | (T) SATB2 | See SOW | 3 | $ - 0 | |||||
| 126 | (T) SMA | NEOGENOMICS | (T) SMA | See SOW | 2 | $ - 0 | |||||
| 127 | (T) SMMHC | NEOGENOMICS | (T) SMMHC | See SOW | 2 | $ - 0 | |||||
| 128 | (T) Somatostatin Receptor, Type 2 | NEOGENOMICS | (T) Somatostatin Receptor, Type 2 | See SOW | 3 | $ - 0 | |||||
| 129 | (T) SOX10 | NEOGENOMICS | (T) SOX10 | See SOW | 2 | $ - 0 | |||||
| 130 | (T) SOX11 | NEOGENOMICS | (T) SOX11 | See SOW | 3 | $ - 0 | |||||
| 131 | (T) Spirochete | NEOGENOMICS | (T) Spirochete | See SOW | 4 | $ - 0 | |||||
| 132 | (T) STAT6 | NEOGENOMICS | (T) STAT6 | See SOW | 5 | $ - 0 | |||||
| 133 | (T) Synaptophysin | NEOGENOMICS | (T) Synaptophysin | See SOW | 2 | $ - 0 | |||||
| 134 | (T) TCL1 | NEOGENOMICS | (T) TCL1 | See SOW | 4 | $ - 0 | |||||
| 135 | (T) TdT | NEOGENOMICS | (T) TdT | See SOW | 6 | $ - 0 | |||||
| 136 | (T) TIA1 | NEOGENOMICS | (T) TIA1 | See SOW | 3 | $ - 0 | |||||
| 137 | (T) TLE1 | NEOGENOMICS | (T) TLE1 | See SOW | 2 | $ - 0 | |||||
| 138 | (T) Toxoplasma | NEOGENOMICS | (T) Toxoplasma | See SOW | 2 | $ - 0 | |||||
| 139 | (T) Trichrome | NEOGENOMICS | (T) Trichrome | See SOW | 4 | $ - 0 | |||||
| 140 | (T) Tryptase | NEOGENOMICS | (T) Tryptase | See SOW | 4 | $ - 0 | |||||
| 141 | (T) TTF1 | NEOGENOMICS | (T) TTF1 | See SOW | 6 | $ - 0 | |||||
| 142 | (T) Uroplakin II | NEOGENOMICS | (T) Uroplakin II | See SOW | 2 | $ - 0 | |||||
| 143 | (T) Uroplakin III | NEOGENOMICS | (T) Uroplakin III | See SOW | 2 | $ - 0 | |||||
| 144 | (T) Villin | NEOGENOMICS | (T) Villin | See SOW | 2 | $ - 0 | |||||
| 145 | (T) WT1 | NEOGENOMICS | (T) WT1 | See SOW | 8 | $ - 0 | |||||
| 146 | (P) NeoTYPE® ALL Profile (Molecular Only) | NEOGENOMICS | (P) NeoTYPE® ALL Profile (Molecular Only) | See SOW | 2 | $ - 0 | |||||
| 147 | (P) Sarcoma Comprehensive NGS Fusion Panel | NEOGENOMICS | (P) Sarcoma Comprehensive NGS Fusion Panel | See SOW | 2 | $ - 0 | |||||
| 148 | (T) B-Cell Gene Rearrangement | NEOGENOMICS | (T) B-Cell Gene Rearrangement | See SOW | 3 | $ - 0 | |||||
| 149 | (T) CXCR4 Mutation Analysis | NEOGENOMICS | (T) CXCR4 Mutation Analysis | See SOW | 2 | $ - 0 | |||||
| 150 | (T) MLH1 Promoter Methylation Analysis | NEOGENOMICS | (T) MLH1 Promoter Methylation Analysis | See SOW | 2 | $ - 0 | |||||
| 151 | (T) MYD88 Mutation Analysis | NEOGENOMICS | (T) MYD88 Mutation Analysis | See SOW | 2 | $ - 0 | |||||
| 152 | (T) T-Cell Receptor Beta Gene Rearrangement | NEOGENOMICS | (T) T-Cell Receptor Beta Gene Rearrangement | See SOW | 6 | $ - 0 | |||||
| 153 | (T) T-Cell Receptor Gamma Gene Rearrangement | NEOGENOMICS | (T) T-Cell Receptor Gamma Gene Rearrangement | See SOW | 6 | $ - 0 | |||||
| 154 | Calcium stain | NEOGENOMICS | Calcium stain | See SOW | 11 | $ - 0 | |||||
| 155 | MLH1 Qualitative | NEOGENOMICS | MLH1 Qualitative | See SOW | 3 | $ - 0 | |||||
| 156 | MSH6 Qualitative | NEOGENOMICS | MSH6 Qualitative | See SOW | 3 | $ - 0 | |||||
| 157 | Periodic Acid Schiff for Fungus (PASF) | NEOGENOMICS | Periodic Acid Schiff for Fungus (PASF) | See SOW | 12 | $ - 0 | |||||
| $ - 0 | |||||||||||
| Total | $ - 0 |
4. Option 3
| CLIN | Brand Name | Brand Name Nomenclature | Manufacturer Part Number | Salient Characteristics | Equivalent Brand | Equivalent Nomenclature | Equivalent Part Number | Equivalent Description Matching Salient Characteristics and/or location of information regarding equal capability | Quantity | Unit Price | Extended Price |
| 1 | (T) DDIT3 (CHOP)(12q13) | NEOGENOMICS | (T) DDIT3 (CHOP)(12q13) | See SOW | 2 | $ - 0 | |||||
| 2 | (T) H&E | NEOGENOMICS | (T) H&E | See SOW | 11 | $ - 0 | |||||
| 3 | (T) HER2 Breast | NEOGENOMICS | (T) HER2 Breast | See SOW | 3 | $ - 0 | |||||
| 4 | (T) HER2 Gastric/GEA | NEOGENOMICS | (T) HER2 Gastric/GEA | See SOW | 2 | $ - 0 | |||||
| 5 | (T) MDM2 | NEOGENOMICS | (T) MDM2 | See SOW | 8 | $ - 0 | |||||
| 6 | (P) AML MRD Flow Panel | NEOGENOMICS | (P) AML MRD Flow Panel | See SOW | 2 | $ - 0 | |||||
| 7 | (P) Amyloid A & P | NEOGENOMICS | (P) Amyloid A & P | See SOW | 3 | $ - 0 | |||||
| 8 | (P) Breast Panel (2 Stain) | NEOGENOMICS | (P) Breast Panel (2 Stain) | See SOW | 4 | $ - 0 | |||||
| 9 | (P) Breast Panel (3 Stain) | NEOGENOMICS | (P) Breast Panel (3 Stain) | See SOW | 4 | $ - 0 | |||||
| 10 | (P) Breast Panel (4 Stain) | NEOGENOMICS | (P) Breast Panel (4 Stain) | See SOW | 2 | $ - 0 | |||||
| 11 | (P) HPV RNA ISH Panel | NEOGENOMICS | (P) HPV RNA ISH Panel | See SOW | 8 | $ - 0 | |||||
| 12 | (P) Mismatch Repair (MMR) IHC Panel Qualitative | NEOGENOMICS | (P) Mismatch Repair (MMR) IHC Panel Qualitative | See SOW | 3 | $ - 0 | |||||
| 13 | (T) AFP | NEOGENOMICS | (T) AFP | See SOW | 4 | $ - 0 | |||||
| 14 | (T) Albumin RNA ISH | NEOGENOMICS | (T) Albumin RNA ISH | See SOW | 3 | $ - 0 | |||||
| 15 | (T) ALK (D5F3) | NEOGENOMICS | (T) ALK (D5F3) | See SOW | 4 | $ - 0 | |||||
| 16 | (T) ALK-1 (for Heme cases) | NEOGENOMICS | (T) ALK-1 (for Heme cases) | See SOW | 17 | $ - 0 | |||||
| 17 | (T) AR | NEOGENOMICS | (T) AR | See SOW | 2 | $ - 0 | |||||
| 18 | (T) AR Qualitative | NEOGENOMICS | (T) AR Qualitative | See SOW | 2 | $ - 0 | |||||
| 19 | (T) Arginase 1 | NEOGENOMICS | (T) Arginase 1 | See SOW | 12 | $ - 0 | |||||
| 20 | (T) BOB1 | NEOGENOMICS | (T) BOB1 | See SOW | 2 | $ - 0 | |||||
| 21 | (T) CA19.9 | NEOGENOMICS | (T) CA19.9 | See SOW | 2 | $ - 0 | |||||
| 22 | (T) Calcitonin | NEOGENOMICS | (T) Calcitonin | See SOW | 2 | $ - 0 | |||||
| 23 | (T) Calponin | NEOGENOMICS | (T) Calponin | See SOW | 2 | $ - 0 | |||||
| 24 | (T) Calretinin | NEOGENOMICS | (T) Calretinin | See SOW | 2 | $ - 0 | |||||
| 25 | (T) CD1a | NEOGENOMICS | (T) CD1a | See SOW | 3 | $ - 0 | |||||
| 26 | (T) CD2 | NEOGENOMICS | (T) CD2 | See SOW | 2 | $ - 0 | |||||
| 27 | (T) CD14 | NEOGENOMICS | (T) CD14 | See SOW | 2 | $ - 0 | |||||
| 28 | (T) CD15 | NEOGENOMICS | (T) CD15 | See SOW | 2 | $ - 0 | |||||
| 29 | (T) CD23 | NEOGENOMICS | (T) CD23 | See SOW | 4 | $ - 0 | |||||
| 30 | (T) CD25 | NEOGENOMICS | (T) CD25 | See SOW | 4 | $ - 0 | |||||
| 31 | (T) CD33 | NEOGENOMICS | (T) CD33 | See SOW | 2 | $ - 0 | |||||
| 32 | (T) CD42b | NEOGENOMICS | (T) CD42b | See SOW | 4 | $ - 0 | |||||
| 33 | (T) CD44 | NEOGENOMICS | (T) CD44 | See SOW | 5 | $ - 0 | |||||
| 34 | (T) CD61 | NEOGENOMICS | (T) CD61 | See SOW | 9 | $ - 0 | |||||
| 35 | (T) CD71 | NEOGENOMICS | (T) CD71 | See SOW | 4 | $ - 0 | |||||
| 36 | (T) CD79a | NEOGENOMICS | (T) CD79a | See SOW | 7 | $ - 0 | |||||
| 37 | (T) CD117 cKIT | NEOGENOMICS | (T) CD117 cKIT | See SOW | 3 | $ - 0 | |||||
| 38 | (T) CD123 | NEOGENOMICS | (T) CD123 | See SOW | 8 | $ - 0 | |||||
| 39 | (T) CD163 | NEOGENOMICS | (T) CD163 | See SOW | 3 | $ - 0 | |||||
| 40 | (T) CEA (Poly) | NEOGENOMICS | (T) CEA (Poly) | See SOW | 3 | $ - 0 | |||||
| 41 | (T) CK 7 | NEOGENOMICS | (T) CK 7 | See SOW | 7 | $ - 0 | |||||
| 42 | (T) CK 19 | NEOGENOMICS | (T) CK 19 | See SOW | 9 | $ - 0 | |||||
| 43 | (T) CK OSCAR | NEOGENOMICS | (T) CK OSCAR | See SOW | 7 | $ - 0 | |||||
| 44 | (T) Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma | NEOGENOMICS | (T) Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma | See SOW | 3 | $ - 0 | |||||
| 45 | (T) CMV by IHC | NEOGENOMICS | (T) CMV by IHC | See SOW | 28 | $ - 0 | |||||
| 46 | (T) cMyc | NEOGENOMICS | (T) cMyc | See SOW | 5 | $ - 0 | |||||
| 47 | (T) Congo Red | NEOGENOMICS | (T) Congo Red | See SOW | 3 | $ - 0 | |||||
| 48 | (T) CXCL13 | NEOGENOMICS | (T) CXCL13 | See SOW | 4 | $ - 0 | |||||
| 49 | (T) Desmin | NEOGENOMICS | (T) Desmin | See SOW | 2 | $ - 0 | |||||
| 50 | (T) DOG1 | NEOGENOMICS | (T) DOG1 | See SOW | 3 | $ - 0 | |||||
| 51 | (T) E-Cadherin | NEOGENOMICS | (T) E-Cadherin | See SOW | 6 | $ - 0 | |||||
| 52 | (T) EBER ISH | NEOGENOMICS | (T) EBER ISH | See SOW | 26 | $ - 0 | |||||
| 53 | (T) EBV (LMP1) | NEOGENOMICS | (T) EBV (LMP1) | See SOW | 2 | $ - 0 | |||||
| 54 | (T) Elastic Stain | NEOGENOMICS | (T) Elastic Stain | See SOW | 3 | $ - 0 | |||||
| 55 | (T) ER | NEOGENOMICS | (T) ER | See SOW | 3 | $ - 0 | |||||
| 56 | (T) ER Qualitative | NEOGENOMICS | (T) ER Qualitative | See SOW | 8 | $ - 0 | |||||
| 57 | (T) ERG | NEOGENOMICS | (T) ERG | See SOW | 7 | $ - 0 | |||||
| 58 | (T) Factor XIIIa | NEOGENOMICS | (T) Factor XIIIa | See SOW | 2 | $ - 0 | |||||
| 59 | (T) Fli-1 | NEOGENOMICS | (T) Fli-1 | See SOW | 2 | $ - 0 | |||||
| 60 | (T) Gastrin | NEOGENOMICS | (T) Gastrin | See SOW | 5 | $ - 0 | |||||
| 61 | (T) GCDFP15 | NEOGENOMICS | (T) GCDFP15 | See SOW | 2 | $ - 0 | |||||
| 62 | (T) Glypican-3 | NEOGENOMICS | (T) Glypican-3 | See SOW | 12 | $ - 0 | |||||
| 63 | (T) GMS | NEOGENOMICS | (T) GMS | See SOW | 12 | $ - 0 | |||||
| 64 | (T) Gram Stain | NEOGENOMICS | (T) Gram Stain | See SOW | 8 | $ - 0 | |||||
| 65 | (T) Granzyme B | NEOGENOMICS | (T) Granzyme B | See SOW | 4 | $ - 0 | |||||
| 66 | (T) H3K27me3 | NEOGENOMICS | (T) H3K27me3 | See SOW | 2 | $ - 0 | |||||
| 67 | (T) H. Pylori | NEOGENOMICS | (T) H. Pylori | See SOW | 7 | $ - 0 | |||||
| 68 | (T) HCG Beta | NEOGENOMICS | (T) HCG Beta | See SOW | 2 | $ - 0 | |||||
| 69 | (T) HER2 (Other) – with Breast Scoring | NEOGENOMICS | (T) HER2 (Other) – with Breast Scoring | See SOW | 7 | $ - 0 | |||||
| 70 | (T) HER2 (Other) – with Gastric Scoring | NEOGENOMICS | (T) HER2 (Other) – with Gastric Scoring | See SOW | 2 | $ - 0 | |||||
| 71 | (T) HER2 Breast | NEOGENOMICS | (T) HER2 Breast | See SOW | 5 | $ - 0 | |||||
| 72 | (T) HER2 Gastric/GEA | NEOGENOMICS | (T) HER2 Gastric/GEA | See SOW | 10 | $ - 0 | |||||
| 73 | (T) HHV8 | NEOGENOMICS | (T) HHV8 | See SOW | 11 | $ - 0 | |||||
| 74 | (T) Histology Other | NEOGENOMICS | (T) Histology Other | See SOW | 5 | $ - 0 | |||||
| 75 | (T) HMB45 | NEOGENOMICS | (T) HMB45 | See SOW | 2 | $ - 0 | |||||
| 76 | (T) HPV RNA ISH High Risk Cocktail | NEOGENOMICS | (T) HPV RNA ISH High Risk Cocktail | See SOW | 9 | $ - 0 | |||||
| 77 | (T) HPV RNA ISH Low Risk Cocktail | NEOGENOMICS | (T) HPV RNA ISH Low Risk Cocktail | See SOW | 9 | $ - 0 | |||||
| 78 | (T) HSV1/2 | NEOGENOMICS | (T) HSV1/2 | See SOW | 11 | $ - 0 | |||||
| 79 | (T) ICOS | NEOGENOMICS | (T) ICOS | See SOW | 3 | $ - 0 | |||||
| 80 | (T) Ig G | NEOGENOMICS | (T) Ig G | See SOW | 11 | $ - 0 | |||||
| 81 | (T) IgG4 | NEOGENOMICS | (T) IgG4 | See SOW | 11 | $ - 0 | |||||
| 82 | (T) Inhibin | NEOGENOMICS | (T) Inhibin | See SOW | 2 | $ - 0 | |||||
| 83 | (T) INI1 | NEOGENOMICS | (T) INI1 | See SOW | 2 | $ - 0 | |||||
| 84 | (T) INSM1 | NEOGENOMICS | (T) INSM1 | See SOW | 4 | $ - 0 | |||||
| 85 | (T) Ki67 | NEOGENOMICS | (T) Ki67 | See SOW | 3 | $ - 0 | |||||
| 86 | (T) Langerin | NEOGENOMICS | (T) Langerin | See SOW | 2 | $ - 0 | |||||
| 87 | (T) LEF1 | NEOGENOMICS | (T) LEF1 | See SOW | 2 | $ - 0 | |||||
| 88 | (T) LMO2 | NEOGENOMICS | (T) LMO2 | See SOW | 2 | $ - 0 | |||||
| 89 | (T) Mammaglobin | NEOGENOMICS | (T) Mammaglobin | See SOW | 5 | $ - 0 | |||||
| 90 | (T) MPO | NEOGENOMICS | (T) MPO | See SOW | 4 | $ - 0 | |||||
| 91 | (T) MSH2 Qualitative | NEOGENOMICS | (T) MSH2 Qualitative | See SOW | 3 | $ - 0 | |||||
| 92 | (T) MUC1 | NEOGENOMICS | (T) MUC1 | See SOW | 2 | $ - 0 | |||||
| 93 | (T) MUC2 | NEOGENOMICS | (T) MUC2 | See SOW | 2 | $ - 0 | |||||
| 94 | (T) MUC5 | NEOGENOMICS | (T) MUC5 | See SOW | 2 | $ - 0 | |||||
| 95 | (T) MUC6 | NEOGENOMICS | (T) MUC6 | See SOW | 2 | $ - 0 | |||||
| 96 | (T) MUM1 | NEOGENOMICS | (T) MUM1 | See SOW | 19 | $ - 0 | |||||
| 97 | (T) NF (Neurofilament) | NEOGENOMICS | (T) NF (Neurofilament) | See SOW | 2 | $ - 0 | |||||
| 98 | (T) NKX2.2 | NEOGENOMICS | (T) NKX2.2 | See SOW | 2 | $ - 0 | |||||
| 99 | (T) NKX3.1 | NEOGENOMICS | (T) NKX3.1 | See SOW | 3 | $ - 0 | |||||
| 100 | (T) OCT2 | NEOGENOMICS | (T) OCT2 | See SOW | 3 | $ - 0 | |||||
| 101 | (T) OCT4 | NEOGENOMICS | (T) OCT4 | See SOW | 4 | $ - 0 | |||||
| 102 | (T) p40 | NEOGENOMICS | (T) p40 | See SOW | 2 | $ - 0 | |||||
| 103 | (T) P63 | NEOGENOMICS | (T) P63 | See SOW | 2 | $ - 0 | |||||
| 104 | (T) P504S | NEOGENOMICS | (T) P504S | See SOW | 2 | $ - 0 | |||||
| 105 | (T) Pan-Cytokeratin | NEOGENOMICS | (T) Pan-Cytokeratin | See SOW | 7 | $ - 0 | |||||
| 106 | (T) PAS | NEOGENOMICS | (T) PAS | See SOW | 2 | $ - 0 | |||||
| 107 | (T) PAX2 | NEOGENOMICS | (T) PAX2 | See SOW | 2 | $ - 0 | |||||
| 108 | (T) PAX5 | NEOGENOMICS | (T) PAX5 | See SOW | 5 | $ - 0 | |||||
| 109 | (T) PD1 | NEOGENOMICS | (T) PD1 | See SOW | 6 | $ - 0 | |||||
| 110 | (T) PD-L1 22C3 FDA (KEYTRUDA®) for Gastric/GEA | NEOGENOMICS | (T) PD-L1 22C3 FDA (KEYTRUDA®) for Gastric/GEA | See SOW | 2 | $ - 0 | |||||
| 111 | (T) PD-L1 22C3 FDA (KEYTRUDA®) for HNSCC (Head and Neck) | NEOGENOMICS | (T) PD-L1 22C3 FDA (KEYTRUDA®) for HNSCC (Head and Neck) | See SOW | 12 | $ - 0 | |||||
| 112 | (T) PD-L1 22C3 FDA for NSCLC | NEOGENOMICS | (T) PD-L1 22C3 FDA for NSCLC | See SOW | 66 | $ - 0 | |||||
| 113 | (T) PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/EAC | NEOGENOMICS | (T) PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/EAC | See SOW | 7 | $ - 0 | |||||
| 114 | (T) PD-L1 28-8 FDA for NSCLC | NEOGENOMICS | (T) PD-L1 28-8 FDA for NSCLC | See SOW | 3 | $ - 0 | |||||
| 115 | (T) PD-L1 SP142 FDA (TECENTRIQ®) for NSCLC | NEOGENOMICS | (T) PD-L1 SP142 FDA (TECENTRIQ®) for NSCLC | See SOW | 2 | $ - 0 | |||||
| 116 | (T) Periodic Acid Schiff with Digestion (PASD) | NEOGENOMICS | (T) Periodic Acid Schiff with Digestion (PASD) | See SOW | 5 | $ - 0 | |||||
| 117 | (T) PgR | NEOGENOMICS | (T) PgR | See SOW | 3 | $ - 0 | |||||
| 118 | (T) PLAP | NEOGENOMICS | (T) PLAP | See SOW | 2 | $ - 0 | |||||
| 119 | (T) PMS2 | NEOGENOMICS | (T) PMS2 | See SOW | 7 | $ - 0 | |||||
| 120 | (T) PMS2 Qualitative | NEOGENOMICS | (T) PMS2 Qualitative | See SOW | 26 | $ - 0 | |||||
| 121 | (T) PSA | NEOGENOMICS | (T) PSA | See SOW | 2 | $ - 0 | |||||
| 122 | (T) PTH | NEOGENOMICS | (T) PTH | See SOW | 2 | $ - 0 | |||||
| 123 | (T) Retinoblastoma Protein (RB) | NEOGENOMICS | (T) Retinoblastoma Protein (RB) | See SOW | 3 | $ - 0 | |||||
| 124 | (T) S100 | NEOGENOMICS | (T) S100 | See SOW | 6 | $ - 0 | |||||
| 125 | (T) SATB2 | NEOGENOMICS | (T) SATB2 | See SOW | 3 | $ - 0 | |||||
| 126 | (T) SMA | NEOGENOMICS | (T) SMA | See SOW | 2 | $ - 0 | |||||
| 127 | (T) SMMHC | NEOGENOMICS | (T) SMMHC | See SOW | 2 | $ - 0 | |||||
| 128 | (T) Somatostatin Receptor, Type 2 | NEOGENOMICS | (T) Somatostatin Receptor, Type 2 | See SOW | 3 | $ - 0 | |||||
| 129 | (T) SOX10 | NEOGENOMICS | (T) SOX10 | See SOW | 2 | $ - 0 | |||||
| 130 | (T) SOX11 | NEOGENOMICS | (T) SOX11 | See SOW | 3 | $ - 0 | |||||
| 131 | (T) Spirochete | NEOGENOMICS | (T) Spirochete | See SOW | 4 | $ - 0 | |||||
| 132 | (T) STAT6 | NEOGENOMICS | (T) STAT6 | See SOW | 5 | $ - 0 | |||||
| 133 | (T) Synaptophysin | NEOGENOMICS | (T) Synaptophysin | See SOW | 2 | $ - 0 | |||||
| 134 | (T) TCL1 | NEOGENOMICS | (T) TCL1 | See SOW | 4 | $ - 0 | |||||
| 135 | (T) TdT | NEOGENOMICS | (T) TdT | See SOW | 6 | $ - 0 | |||||
| 136 | (T) TIA1 | NEOGENOMICS | (T) TIA1 | See SOW | 3 | $ - 0 | |||||
| 137 | (T) TLE1 | NEOGENOMICS | (T) TLE1 | See SOW | 2 | $ - 0 | |||||
| 138 | (T) Toxoplasma | NEOGENOMICS | (T) Toxoplasma | See SOW | 2 | $ - 0 | |||||
| 139 | (T) Trichrome | NEOGENOMICS | (T) Trichrome | See SOW | 4 | $ - 0 | |||||
| 140 | (T) Tryptase | NEOGENOMICS | (T) Tryptase | See SOW | 4 | $ - 0 | |||||
| 141 | (T) TTF1 | NEOGENOMICS | (T) TTF1 | See SOW | 6 | $ - 0 | |||||
| 142 | (T) Uroplakin II | NEOGENOMICS | (T) Uroplakin II | See SOW | 2 | $ - 0 | |||||
| 143 | (T) Uroplakin III | NEOGENOMICS | (T) Uroplakin III | See SOW | 2 | $ - 0 | |||||
| 144 | (T) Villin | NEOGENOMICS | (T) Villin | See SOW | 2 | $ - 0 | |||||
| 145 | (T) WT1 | NEOGENOMICS | (T) WT1 | See SOW | 8 | $ - 0 | |||||
| 146 | (P) NeoTYPE® ALL Profile (Molecular Only) | NEOGENOMICS | (P) NeoTYPE® ALL Profile (Molecular Only) | See SOW | 2 | $ - 0 | |||||
| 147 | (P) Sarcoma Comprehensive NGS Fusion Panel | NEOGENOMICS | (P) Sarcoma Comprehensive NGS Fusion Panel | See SOW | 2 | $ - 0 | |||||
| 148 | (T) B-Cell Gene Rearrangement | NEOGENOMICS | (T) B-Cell Gene Rearrangement | See SOW | 3 | $ - 0 | |||||
| 149 | (T) CXCR4 Mutation Analysis | NEOGENOMICS | (T) CXCR4 Mutation Analysis | See SOW | 2 | $ - 0 | |||||
| 150 | (T) MLH1 Promoter Methylation Analysis | NEOGENOMICS | (T) MLH1 Promoter Methylation Analysis | See SOW | 2 | $ - 0 | |||||
| 151 | (T) MYD88 Mutation Analysis | NEOGENOMICS | (T) MYD88 Mutation Analysis | See SOW | 2 | $ - 0 | |||||
| 152 | (T) T-Cell Receptor Beta Gene Rearrangement | NEOGENOMICS | (T) T-Cell Receptor Beta Gene Rearrangement | See SOW | 6 | $ - 0 | |||||
| 153 | (T) T-Cell Receptor Gamma Gene Rearrangement | NEOGENOMICS | (T) T-Cell Receptor Gamma Gene Rearrangement | See SOW | 6 | $ - 0 | |||||
| 154 | Calcium stain | NEOGENOMICS | Calcium stain | See SOW | 11 | $ - 0 | |||||
| 155 | MLH1 Qualitative | NEOGENOMICS | MLH1 Qualitative | See SOW | 3 | $ - 0 | |||||
| 156 | MSH6 Qualitative | NEOGENOMICS | MSH6 Qualitative | See SOW | 3 | $ - 0 | |||||
| 157 | Periodic Acid Schiff for Fungus (PASF) | NEOGENOMICS | Periodic Acid Schiff for Fungus (PASF) | See SOW | 12 | $ - 0 | |||||
| $ - 0 | |||||||||||
| Total | $ - 0 |
5. Option 4
| CLIN | Brand Name | Brand Name Nomenclature | Manufacturer Part Number | Salient Characteristics | Equivalent Brand | Equivalent Nomenclature | Equivalent Part Number | Equivalent Description Matching Salient Characteristics and/or location of information regarding equal capability | Quantity | Unit Price | Extended Price |
| 1 | (T) DDIT3 (CHOP)(12q13) | NEOGENOMICS | (T) DDIT3 (CHOP)(12q13) | See SOW | 2 | $ - 0 | |||||
| 2 | (T) H&E | NEOGENOMICS | (T) H&E | See SOW | 11 | $ - 0 | |||||
| 3 | (T) HER2 Breast | NEOGENOMICS | (T) HER2 Breast | See SOW | 3 | $ - 0 | |||||
| 4 | (T) HER2 Gastric/GEA | NEOGENOMICS | (T) HER2 Gastric/GEA | See SOW | 2 | $ - 0 | |||||
| 5 | (T) MDM2 | NEOGENOMICS | (T) MDM2 | See SOW | 8 | $ - 0 | |||||
| 6 | (P) AML MRD Flow Panel | NEOGENOMICS | (P) AML MRD Flow Panel | See SOW | 2 | $ - 0 | |||||
| 7 | (P) Amyloid A & P | NEOGENOMICS | (P) Amyloid A & P | See SOW | 3 | $ - 0 | |||||
| 8 | (P) Breast Panel (2 Stain) | NEOGENOMICS | (P) Breast Panel (2 Stain) | See SOW | 4 | $ - 0 | |||||
| 9 | (P) Breast Panel (3 Stain) | NEOGENOMICS | (P) Breast Panel (3 Stain) | See SOW | 4 | $ - 0 | |||||
| 10 | (P) Breast Panel (4 Stain) | NEOGENOMICS | (P) Breast Panel (4 Stain) | See SOW | 2 | $ - 0 | |||||
| 11 | (P) HPV RNA ISH Panel | NEOGENOMICS | (P) HPV RNA ISH Panel | See SOW | 8 | $ - 0 | |||||
| 12 | (P) Mismatch Repair (MMR) IHC Panel Qualitative | NEOGENOMICS | (P) Mismatch Repair (MMR) IHC Panel Qualitative | See SOW | 3 | $ - 0 | |||||
| 13 | (T) AFP | NEOGENOMICS | (T) AFP | See SOW | 4 | $ - 0 | |||||
| 14 | (T) Albumin RNA ISH | NEOGENOMICS | (T) Albumin RNA ISH | See SOW | 3 | $ - 0 | |||||
| 15 | (T) ALK (D5F3) | NEOGENOMICS | (T) ALK (D5F3) | See SOW | 4 | $ - 0 | |||||
| 16 | (T) ALK-1 (for Heme cases) | NEOGENOMICS | (T) ALK-1 (for Heme cases) | See SOW | 17 | $ - 0 | |||||
| 17 | (T) AR | NEOGENOMICS | (T) AR | See SOW | 2 | $ - 0 | |||||
| 18 | (T) AR Qualitative | NEOGENOMICS | (T) AR Qualitative | See SOW | 2 | $ - 0 | |||||
| 19 | (T) Arginase 1 | NEOGENOMICS | (T) Arginase 1 | See SOW | 12 | $ - 0 | |||||
| 20 | (T) BOB1 | NEOGENOMICS | (T) BOB1 | See SOW | 2 | $ - 0 | |||||
| 21 | (T) CA19.9 | NEOGENOMICS | (T) CA19.9 | See SOW | 2 | $ - 0 | |||||
| 22 | (T) Calcitonin | NEOGENOMICS | (T) Calcitonin | See SOW | 2 | $ - 0 | |||||
| 23 | (T) Calponin | NEOGENOMICS | (T) Calponin | See SOW | 2 | $ - 0 | |||||
| 24 | (T) Calretinin | NEOGENOMICS | (T) Calretinin | See SOW | 2 | $ - 0 | |||||
| 25 | (T) CD1a | NEOGENOMICS | (T) CD1a | See SOW | 3 | $ - 0 | |||||
| 26 | (T) CD2 | NEOGENOMICS | (T) CD2 | See SOW | 2 | $ - 0 | |||||
| 27 | (T) CD14 | NEOGENOMICS | (T) CD14 | See SOW | 2 | $ - 0 | |||||
| 28 | (T) CD15 | NEOGENOMICS | (T) CD15 | See SOW | 2 | $ - 0 | |||||
| 29 | (T) CD23 | NEOGENOMICS | (T) CD23 | See SOW | 4 | $ - 0 | |||||
| 30 | (T) CD25 | NEOGENOMICS | (T) CD25 | See SOW | 4 | $ - 0 | |||||
| 31 | (T) CD33 | NEOGENOMICS | (T) CD33 | See SOW | 2 | $ - 0 | |||||
| 32 | (T) CD42b | NEOGENOMICS | (T) CD42b | See SOW | 4 | $ - 0 | |||||
| 33 | (T) CD44 | NEOGENOMICS | (T) CD44 | See SOW | 5 | $ - 0 | |||||
| 34 | (T) CD61 | NEOGENOMICS | (T) CD61 | See SOW | 9 | $ - 0 | |||||
| 35 | (T) CD71 | NEOGENOMICS | (T) CD71 | See SOW | 4 | $ - 0 | |||||
| 36 | (T) CD79a | NEOGENOMICS | (T) CD79a | See SOW | 7 | $ - 0 | |||||
| 37 | (T) CD117 cKIT | NEOGENOMICS | (T) CD117 cKIT | See SOW | 3 | $ - 0 | |||||
| 38 | (T) CD123 | NEOGENOMICS | (T) CD123 | See SOW | 8 | $ - 0 | |||||
| 39 | (T) CD163 | NEOGENOMICS | (T) CD163 | See SOW | 3 | $ - 0 | |||||
| 40 | (T) CEA (Poly) | NEOGENOMICS | (T) CEA (Poly) | See SOW | 3 | $ - 0 | |||||
| 41 | (T) CK 7 | NEOGENOMICS | (T) CK 7 | See SOW | 7 | $ - 0 | |||||
| 42 | (T) CK 19 | NEOGENOMICS | (T) CK 19 | See SOW | 9 | $ - 0 | |||||
| 43 | (T) CK OSCAR | NEOGENOMICS | (T) CK OSCAR | See SOW | 7 | $ - 0 | |||||
| 44 | (T) Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma | NEOGENOMICS | (T) Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma | See SOW | 3 | $ - 0 | |||||
| 45 | (T) CMV by IHC | NEOGENOMICS | (T) CMV by IHC | See SOW | 28 | $ - 0 | |||||
| 46 | (T) cMyc | NEOGENOMICS | (T) cMyc | See SOW | 5 | $ - 0 | |||||
| 47 | (T) Congo Red | NEOGENOMICS | (T) Congo Red | See SOW | 3 | $ - 0 | |||||
| 48 | (T) CXCL13 | NEOGENOMICS | (T) CXCL13 | See SOW | 4 | $ - 0 | |||||
| 49 | (T) Desmin | NEOGENOMICS | (T) Desmin | See SOW | 2 | $ - 0 | |||||
| 50 | (T) DOG1 | NEOGENOMICS | (T) DOG1 | See SOW | 3 | $ - 0 | |||||
| 51 | (T) E-Cadherin | NEOGENOMICS | (T) E-Cadherin | See SOW | 6 | $ - 0 | |||||
| 52 | (T) EBER ISH | NEOGENOMICS | (T) EBER ISH | See SOW | 26 | $ - 0 | |||||
| 53 | (T) EBV (LMP1) | NEOGENOMICS | (T) EBV (LMP1) | See SOW | 2 | $ - 0 | |||||
| 54 | (T) Elastic Stain | NEOGENOMICS | (T) Elastic Stain | See SOW | 3 | $ - 0 | |||||
| 55 | (T) ER | NEOGENOMICS | (T) ER | See SOW | 3 | $ - 0 | |||||
| 56 | (T) ER Qualitative | NEOGENOMICS | (T) ER Qualitative | See SOW | 8 | $ - 0 | |||||
| 57 | (T) ERG | NEOGENOMICS | (T) ERG | See SOW | 7 | $ - 0 | |||||
| 58 | (T) Factor XIIIa | NEOGENOMICS | (T) Factor XIIIa | See SOW | 2 | $ - 0 | |||||
| 59 | (T) Fli-1 | NEOGENOMICS | (T) Fli-1 | See SOW | 2 | $ - 0 | |||||
| 60 | (T) Gastrin | NEOGENOMICS | (T) Gastrin | See SOW | 5 | $ - 0 | |||||
| 61 | (T) GCDFP15 | NEOGENOMICS | (T) GCDFP15 | See SOW | 2 | $ - 0 | |||||
| 62 | (T) Glypican-3 | NEOGENOMICS | (T) Glypican-3 | See SOW | 12 | $ - 0 | |||||
| 63 | (T) GMS | NEOGENOMICS | (T) GMS | See SOW | 12 | $ - 0 | |||||
| 64 | (T) Gram Stain | NEOGENOMICS | (T) Gram Stain | See SOW | 8 | $ - 0 | |||||
| 65 | (T) Granzyme B | NEOGENOMICS | (T) Granzyme B | See SOW | 4 | $ - 0 | |||||
| 66 | (T) H3K27me3 | NEOGENOMICS | (T) H3K27me3 | See SOW | 2 | $ - 0 | |||||
| 67 | (T) H. Pylori | NEOGENOMICS | (T) H. Pylori | See SOW | 7 | $ - 0 | |||||
| 68 | (T) HCG Beta | NEOGENOMICS | (T) HCG Beta | See SOW | 2 | $ - 0 | |||||
| 69 | (T) HER2 (Other) – with Breast Scoring | NEOGENOMICS | (T) HER2 (Other) – with Breast Scoring | See SOW | 7 | $ - 0 | |||||
| 70 | (T) HER2 (Other) – with Gastric Scoring | NEOGENOMICS | (T) HER2 (Other) – with Gastric Scoring | See SOW | 2 | $ - 0 | |||||
| 71 | (T) HER2 Breast | NEOGENOMICS | (T) HER2 Breast | See SOW | 5 | $ - 0 | |||||
| 72 | (T) HER2 Gastric/GEA | NEOGENOMICS | (T) HER2 Gastric/GEA | See SOW | 10 | $ - 0 | |||||
| 73 | (T) HHV8 | NEOGENOMICS | (T) HHV8 | See SOW | 11 | $ - 0 | |||||
| 74 | (T) Histology Other | NEOGENOMICS | (T) Histology Other | See SOW | 5 | $ - 0 | |||||
| 75 | (T) HMB45 | NEOGENOMICS | (T) HMB45 | See SOW | 2 | $ - 0 | |||||
| 76 | (T) HPV RNA ISH High Risk Cocktail | NEOGENOMICS | (T) HPV RNA ISH High Risk Cocktail | See SOW | 9 | $ - 0 |
This is the start of the file's text. The full file is on GovTribe.
File details come from the government source that posted it. Updated .